Devices and methods for skin treatment

Information

  • Patent Grant
  • 11883621
  • Patent Number
    11,883,621
  • Date Filed
    Thursday, February 6, 2020
    4 years ago
  • Date Issued
    Tuesday, January 30, 2024
    3 months ago
  • Inventors
  • Original Assignees
    • HydraFacial LLC (Long Beach, CA, US)
  • Examiners
    • Arble; Jessica
    Agents
    • Knobbe Martens Olson & Bear, LLP
Abstract
According to some embodiments, a system for treating skin includes a handpiece assembly comprising a tip and a main body portion, the main body portion comprising an interior cavity and at least one canister configured to store at least one of a treatment material and a waste material. The treatment material and/or the waste material is in fluid communication with the tip.
Description
BACKGROUND
Field

This application relates in general to the field of skin treatment, and more specifically to apparatuses and methods for treating a person's skin.


Description of the Related Art

Abrasion of the outer layer or epidermis of the skin is desirable to smooth or blend scars, blemishes, or other skin conditions that may be caused by, for example, acne, sun exposure, and aging. Standard techniques used to abrade the skin have generally been separated into two fields referred to as dermabrasion and microdermabrasion. Both techniques remove portions of the epidermis called the stratum corneum, which the body interprets as a mild injury. The body then replaces the lost skin cells, resulting in a new outer layer of skin. Additionally, despite the mild edema and erythema associated with the procedures, the skin looks and feels smoother because of the new outer layer of skin.


Dermabrasion refers to a procedure in which the surface of the skin is removed due to mechanical rubbing by a handpiece with an abrasive element that is often in the form of a burr, wheel, or disc. This process tends to be painful and messy. In fact, the procedure is sometimes painful enough to require a local anesthetic. Dermabrasion leaves the skin red and raw-looking. The removed skin can take several months to regrow and heal. Recent efforts have led to the use of lasers instead of abrasive elements, which have resulted in less bleeding, but the pain and mess remains.


Efforts have been made to decrease the mess caused by the process waste, such as removed skin and blood, by adding a suction element. As the process waste is drawn into the suction opening, skin that has not been removed is also pulled against the grit surrounding the suction opening, so the procedure remains fairly messy due to the abrasion that takes place outside of the handpiece by the grit.


Microdermabrasion refers generally to a procedure in which the surface of the skin is removed due to mechanical rubbing by a handpiece emitting a stream of sand or grit. For example, a handpiece can be used to direct an air flow containing tiny crystals of aluminum oxide, sodium chloride, or sodium bicarbonate. The momentum of the grit tends to wear away two to three cell layers of the skin with each pass of the handpiece. Alternatively, new “crystal-free” microdermabrasion techniques utilize a diamond-tipped handpiece without a stream of grit.


Efforts to add a suction element have been more successful in microdermabrasion than in dermabrasion because the handpiece applying the stream of grit is more controllable to a localized area. That is, as the removed skin is drawn into the suction opening, skin that has not been removed is also pulled towards the handpiece where it is treated with the grit stream, allowing for simultaneous local treatment and suction.


Microdermabrasion removes moisture from the skin, so the procedure is always followed by the application of moisturizing creams. However, similar to topical application of moisturizing creams prior to microdermabrasion, the moisturizing elements only work as deep as the active ingredients can passively migrate through the remaining epidermis.


SUMMARY

According to some embodiments, a system for treating skin includes a handpiece assembly comprising a tip and a main body portion, the main body portion comprising an interior cavity and a canister configured to store at least one treatment or waste material. The treatment or waste material is in fluid communication with the tip.


In some embodiments, the system further comprises a fluid transfer device for transferring the treatment or waste material to and from the canister. In other embodiments, the system further includes a conduit configured to place the canister in fluid communication with the tip. In still other arrangements, the conduit is routed within the interior cavity of the main body portion. In another embodiment, the conduit comprises at least two passages with each passage configured to transfer a different material to or from the canister.


According to some embodiments, the handpiece assembly and the canister form a unitary structure. In alternative embodiments, the handpiece assembly and the canister are substantially separated. In one embodiment, the canister comprises at least one compartment which may be configured to contain a treatment fluid and/or waste materials. In other embodiments, the treatment fluid comprises a serum. In yet other arrangements, the tip of the handpiece assembly is removable.





BRIEF DESCRIPTION OF THE DRAWINGS

These and other features, aspects and advantages of the present invention are described with reference to drawings of certain preferred embodiments, which are intended to illustrate, but not to limit, the present invention. The drawings include twenty-eight (28) figures. It is to be understood that the attached drawings are for the purpose of illustrating concepts of the present invention and may not be to scale.



FIG. 1 illustrates a perspective view of a handpiece assembly for use in a skin treatment system according to one embodiment;



FIG. 2A illustrates a perspective view of one embodiment of a conduit adapted for use in the handpiece assembly of FIG. 1;



FIG. 2B illustrates a cross-sectional view of one embodiment of the tubing of FIG. 2A;



FIG. 3 illustrates a perspective view of a handpiece assembly with a portion of the exterior surface removed to reveal an interior portion of the assembly according to one embodiment;



FIG. 4 schematically illustrates one embodiment of a skin treatment system according to one embodiment;



FIG. 5 illustrates a perspective view of a skin treatment system comprising a handpiece assembly and a canister according to one embodiment;



FIG. 6A illustrates a perspective view of a combination storage and waste canister in accordance with another embodiment;



FIG. 6B illustrates a perspective view of a combination storage and waste canister in accordance with yet another embodiment;



FIG. 7 illustrates a perspective view of another embodiment of a handpiece assembly;



FIG. 8 illustrates a perspective view of an embodiment of a combination storage and waste canister configured to be used with the handpiece assembly of FIG. 7;



FIG. 9 schematically illustrates one embodiment of the distal end of a handpiece assembly having a tip that is configured to tilt or pivot;



FIG. 10 illustrates a perspective view of a cartridge or other container comprising a treatment fluid or other material according to one embodiment;



FIG. 11 illustrates a cross-sectional view of a handpiece assembly or other portion of the treatment system configured to receive the cartridge or container of FIG. 10;



FIG. 12 illustrates a perspective view of a handpiece assembly according to another embodiment;



FIG. 13 illustrates a cross-sectional view of a portion of a handpiece assembly configured to receive a cartridge or other container according to one embodiment;



FIG. 14 illustrates a perspective view of waste cartridge or container configured for use with a skin treatment system according to one embodiment;



FIG. 15 illustrates a perspective view of a handpiece assembly according to one embodiment;



FIG. 16 illustrates a cartridge or other container configured for placement within a corresponding area of the handpiece assembly of FIG. 15;



FIG. 17 illustrates a handpiece assembly in fluid communication with a fluid transfer system and a waste canister according to one embodiment;



FIGS. 18 and 19 illustrate an embodiment of a handpiece assembly;



FIG. 20A illustrates a perspective view of a handpiece assembly in fluid communication with a waste canister in accordance with one embodiment;



FIG. 20B illustrates a top perspective view of one embodiment of a removable tip adapted for placement on a handpiece assembly;



FIG. 20C illustrates a bottom perspective view of the removable tip of FIG. 20B;



FIG. 21 illustrates a perspective view of another embodiment of a handpiece assembly;



FIG. 22 illustrates a perspective view of a base charging member configured to receive a handpiece assembly according to one embodiment;



FIG. 23 illustrates a perspective view of a skin treatment system comprising a handpiece assembly and a base member having a waste canister according to one embodiment; and



FIG. 24 illustrates a side elevation view of the system of FIG. 23.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS


FIG. 1 illustrates one embodiment of a handpiece assembly 10 configured for use in a skin treatment system which may be used to perform one or more treatments on a person's skin. In the depicted embodiment, the handpiece assembly 10 comprises an outer housing 14 that can be grasped or otherwise manipulated by a user. As shown, the housing 14 can include a curved shape. In other embodiments, the shape, size and/or other details regarding the housing 14 can vary as desired.


With continued reference to FIG. 1, the handpiece assembly 10 can include a tip 20 that is configured to contact or substantially contact the skin or other surface being treated. According to some embodiments, as illustrated in FIG. 1, the tip 20 can be removable. Thus, the tip 20 can be easily changed for cleaning, hygienic or other purposes. For example, depending on the type of skin treatment procedure being performed, a user can select a tip 20 having a specific pattern or features along the distal end. Non-limiting examples of the various types of tips 20 that may be attached to the handpiece assembly 10 are disclosed in U.S. patent application Ser. No. 11/392,348, filed Mar. 29, 2006, the entirety to which is hereby incorporated by reference herein.


In arrangements where a removable tip 20 is used, the handpiece assembly 10 can include an interface portion 30 along its distal end that is configured to securely receive the tip 20. In FIG. 1, the interface portion 30 comprises an O-ring 40 or other sealing member to help prevent or reduce the likelihood of leaks. In other embodiments, one or more other types of gaskets or similar devices can be used, either in lieu of or in addition to an O-ring 40.


With continued reference to FIG. 1, the interface portion 30 can include one or more openings 44, 46 or ports. In some embodiments, these openings 44, 46 are configured to transfer fluids and/or other materials to and/or from the tip 20. For example, in the depicted embodiment, the interface portion 30 comprises two fluid delivery openings 44 positioned along the periphery and one fluid suction opening 46 positioned along the center of the handpiece assembly 10. In other embodiments, however, the number, location, spacing, shape, size and/or other details of the openings 44, 46 can vary as desired or required.


One or more conduits 50 can be placed in fluid communication with the openings 44, 46, and thus, at least a portion of the tip 20 of the handpiece assembly 10. The conduits 50 can be configured to transfer (e.g., deliver, withdraw, etc.) fluids or other materials to and/or from the distal end of the handpiece assembly 10. As shown in FIG. 1, the conduit 50 can be positioned at least partially within an interior portion of a handpiece assembly 10. In the depicted embodiment, the conduit 50 extends out of the proximal end of the handpiece assembly 10.



FIG. 2A illustrates one embodiment of a conduit 50 that is configured for use in a handpiece assembly 10. As shown, the conduit 50 can include a delivery passage 54 and a suction passage 56. In other embodiments, the conduit 50 can comprise more or fewer passages, as desired or required by a particular application or use. In addition, the size, shape and other details of the passages 54, 56 can be different than illustrated in FIGS. 2A and 2B. The conduit 50 can comprise tubing, pipe and/or the like. Further, the conduit 50 can include one or more rigid, semi-rigid and/or flexible materials, such as, for example, rubber, plastic, other polymeric materials, other synthetic materials, metal or the like.


With continued reference to FIG. 2A, the various passages 54, 56 of the conduit 50 can be co-molded or otherwise produced as a unitary structure. In FIG. 2A, the passages 54, 56 are attached to each other along a portion of the conduit 50 and separated from each other along another portion of the conduit 50. According to some embodiments, the conduit 50 can be manufactured using extrusion or other production method. In other arrangements, individual passages that connect to the handpiece assembly 10 are separate members that may or may not be attached to one another. For example, in one embodiment, the passages 54, 56 can comprise separate rubber tubing portions that are joined to each other using adhesives, clips, tape, fasteners and/or one or more other attachment methods or devices. The shape, size and/or other details of the passages 54, 56 can be different than illustrated herein.



FIG. 3 illustrates an exploded perspective view of the handpiece assembly 10 of FIG. 1 with a portion of the outer housing 14 removed to reveal an interior area. As shown, an interior of the handpiece assembly 10 can comprise one or more tabs 18, guides, other fasteners and/or other members that are shaped, sized and otherwise configured to receive and secure one or more conduits 50 extending within the assembly 10. By way of example, in FIG. 3, a small portion of a conduit 50 is shown (in phantom) within one of the tabs 18. In the illustrated embodiment, the handpiece assembly 10 includes a total of two tabs 18. However, the quantity, type, shape, size and/or other details of the tabs 18 or other members can vary. Further, the proximal end of the handpiece assembly 10 can comprise an opening 16 or other slot through which a conduit 50 and/or other items can extend.


With continued reference to FIG. 3, the interface portion 30 of the handpiece assembly 10 can include one or more ports 34, 36 that are configured to attach to passages 54, 56 of a conduit 50. For example, in FIG. 3, the delivery passage 54 is shown (in phantom) as being associated with a first port 34 and the suction passage 56 is shown (in phantom) as being associated with a second port 36. In other embodiments, a handpiece assembly 10 comprises more or fewer ports, as desired or required. In addition, the size, shape, type and/or other details of the ports can vary. In some embodiments, once the tubing 50 is properly secured to the ports 34, 36 of the handpiece assembly, the delivery passage 54 can be placed in fluid communication with the one or more delivery openings 44. Likewise, the suction passage 56 can be placed in fluid communication with the one or more suction openings 46. Consequently, one or more fluids or other materials can be selectively transferred (e.g., delivered to and/or removed from) the tip 20 of the handpiece assembly 10.


As illustrated in FIG. 3, the assembly 10 can be configured such that a single port 36 can be in fluid communication with two or more openings 46 located along a distal surface of the interface portion 30. In other embodiments, a single opening along the distal surface of the interface portion 30 can be in fluid communication with two or more ports. Thus, the interface portion 30 can include one or more internal channels, flow splitting devices, flow control valves and/or any other devices or features that can selectively affect the flow of fluids therethrough. This can apply to delivery and/or suction ports and openings, as desired or required by a particular application.


The use of a conduit 50 that extends within an interior cavity of the handpiece assembly 10 can provide one or more advantages or benefits. For example, such designs can permit a user to easily remove, attach or replace a conduit 50 between or during a treatment or procedure. In addition, contamination of an interior of the handpiece assembly 10 can be reduced or eliminated because fluids or other substances transmitted through the handpiece assembly 10 are fully contained within the passages 54, 56 of the conduit 50.



FIG. 4 schematically illustrates one embodiment of a skin treatment system 6A. The depicted treatment system 6A comprises a handpiece assembly 10, a conduit 50, a fluid transfer device 70 (e.g., pump) in fluid communication with the conduit 50 and a canister 100 or other container. As shown, the handpiece assembly 10 can include a tip 20 that is adapted to contact and treat the skin S. A conduit 50 having a delivery passage 54 and a suction (e.g., removal) passage 56 can be attached to the handpiece assembly 10 and placed in fluid communication with the tip 20. In addition, a pump 70 or other fluid transfer device can be placed in fluid communication with the conduit 50 (e.g., the suction passage 56) to assist in transferring fluids or other materials to and/or from the tip 20.


With continued reference to FIG. 4, the canister 100 or other container can comprise a storage compartment 104 and a waste compartment 106. In other arrangements, the canister 100 can include more or fewer compartments, as desired or required. For example, the canister 100 can include two or more storage compartments, each of which is configured to store a different fluid and/or other treatment media. In some embodiments, the canister 100 comprises a unitary structure having one or more baffles 105 or other dividing members to create two or more separate compartments 104, 106. However, in other embodiments, the system 6A comprises two or more separate canisters that are not part of a unitary structure or that are not attached to each other.


In FIG. 4, when the tip 20 is placed against the surface of the skin S to be treated, a pump 70 or other fluid transfer device can be used to draw a treatment media (e.g., water, saline, other fluids, other materials, etc.) from the storage compartment 104 and through the delivery passage 54. At the same time, the pump 70 can remove waste materials from the treatment surface to the waste compartment 106 via the suction passage 56. In other embodiments, one or more other methods and/or devices for delivering and/or withdrawing fluid or other materials to and/or from the distal end of the handpiece assembly 10 can be used.


As illustrated in FIG. 5, a handpiece assembly 10 and a conduit 50 of a treatment system 6B can be placed in fluid communication with a canister 100. The illustrated canister 100 comprises a base 101 and one or more compartments 104, 106. As discussed, the canister 100 can include one or more storage compartments 104 and/or waste compartments 106 that are separated by a baffle 105 or other separation member. The various compartments 104, 106 can be placed in fluid communication with one or more passages 54, 56 of the conduit 50 to selectively transfer fluids and/or other materials to and/or from a handpiece assembly 10. In addition, the system 6B can include a pump or other fluid transfer device (not shown). For example, in one embodiment, a pump is placed within or near the base 101. In other arrangements, the pump is positioned in one or more other locations (e.g., external to the base 101).


With continued reference to FIG. 5, the canister 100 can include a lid 102 or other cover member that permits a user to selectively access the interior of the compartments 104, 106 for filling, emptying, cleaning and/or any other task. In some embodiments, the lid 102 comprises a hinge 110 or other device that facilitates accessing the interior of the various compartments 104, 106.


Another embodiment of a canister 200 is illustrated in FIG. 6A. In the depicted arrangement, the canister 200 comprises a storage compartment 204 and a waste compartment 206. As discussed, however, in other embodiments, the canister 200 can comprise more or fewer compartments, as desired or required. The compartments 204, 206 can be separated by a baffle 205 or another separation member. In addition, the canister can include a removable lid 202 that permits a user to access the interior of the compartments 204, 206. In FIG. 6A, each compartment 204, 206 comprises a fitting 214, 216 or similar member to which conduits or passages 54, 56 of a conduit (e.g., tubing, pipe, etc.) can attach. Thus, the conduit can be placed in fluid communication with the various compartments 204, 206 of the canister 200. In other embodiments, the fittings 214, 216 or ports can be located in one or more other locations of the canister 200 (e.g., the bottom, side, etc.).


A different embodiment of a canister 200A is illustrated in FIG. 6B. As with other embodiments, the illustrated canister 200A comprises a supply compartment 204A and a waste compartment 206A that are separated by a baffle 205A or other member. As shown, the canister 200A can comprise a base 201A and a lid 202A or other cover member. In addition, the compartments 204A, 206A can comprise one or more internal channels or conduits 274A, 276A that facilitate in the transfer of fluids or other materials into and/or out of the canister 200A. In some embodiments, the canister 200A is configured to move fluids to and from a handpiece assembly 10 in a manner similar to what is schematically described in FIG. 4.



FIG. 7 illustrates a handpiece assembly 310 according to another embodiment. In the depicted arrangement, the handpiece assembly 310 comprises a main body portion 314 and a tip 320 that is configured to contact and treat the skin. In addition, in the illustrated embodiment, the proximal end 311 of the assembly 310 includes a canister 400. Thus, unlike other arrangements disclosed herein, the depicted canister 400 is physically attached to and incorporated into the handpiece assembly 310. In one embodiment, the canister 400 can be separated and/or attached to the main body portion 314 of the handpiece assembly 310 by manipulating a release tab 401, button or other feature. One or more gaskets, O-rings or other members (not shown) can be positioned between the main body portion 314 and the canister 400 in order to reduce the likelihood of leaks.


Accordingly, a user can easily and conveniently handle and manipulate the handpiece assembly 310 illustrated in FIG. 7 (or variations thereof) because the canister 400 and the main body portion 314 of the assembly 310 are self contained within a single structure. In some embodiments, the handpiece assembly 310 includes an internal pump or other fluid transfer device within its main body portion 314. Alternatively, a fluid transfer device and/or any other component can be positioned outside of the handpiece assembly 310 and/or at any other location. Such components can be attached to or separate from the handpiece assembly, as desired or required.



FIG. 8 illustrates one embodiment of a canister 400 configured for use with a self-contained handpiece assembly 310 such as the one as illustrated in FIG. 7. As shown, the canister 400 can comprise a delivery compartment 404 in which one or more treatment fluids or other materials can be placed. In addition, the canister 400 can comprise a waste compartment 406 to which fluids, exfoliated skin and/or other substances withdrawn from the treatment surface can be directed. As with other embodiments disclosed herein, the canister 400 can comprise a baffle 405 or other separation member. In other embodiments, completely separate canisters can be attached to the proximal end of the handpiece assembly 310 (e.g., one or more delivery canisters, a waste canister, etc.).


With continued reference to FIG. 8, the canister 400 can comprise one or more ports 414, 416 or other fittings through which fluids or other substances can be transferred (e.g., between the tip 320 and the canister 400). According to some embodiments, the canister 400 is configured to lock to the main body portion 314 using one or more devices or methods, such as, for example, locking tabs, clasps, magnetic connectors, other fasteners and/or the like.


Any of the embodiments of a handpiece assembly disclosed herein can comprise a tip that swivels, rotates and/or otherwise moves relative to a main body portion. Such a feature can facilitate moving and manipulating a handpiece assembly along a person's skin surface during a treatment procedure. This can be particularly significant when the treatment surface is highly contoured.


In the embodiment illustrated in FIG. 9, a handpiece assembly 510 comprises a joint 515, hinge or other movement mechanism (e.g., ball joint or mechanism, swivel joint or mechanism, etc.). In the illustrated arrangement, the joint 515 is generally located between the tip 520 and the main body portion 514 of the handpiece assembly 510. As illustrated in phantom, such a joint 515 or other mechanism can advantageously permit a tip 520 to be moved relative to the adjacent body portion 514. For example, in some embodiments, the body portion 514 can be moved relative to the tip 520 between a first position 514A and a second position 514B. In some embodiments, the passages of a conduit (not shown) are configured to pass through the joint 514 (e.g., for passages to be in fluid communication from the main body portion 514 to the tip 520 through the joint 515) to permit fluids or other materials to be transferred to and/or from the working surface 522 of the tip 520 during the operation of the handpiece assembly 510.


With respect to any of the embodiments discussed and/or illustrated herein, the handpiece assembly, pump or other fluid transfer device and/or any other component of the skin treatment system can be powered using one or more power sources. For example, in some embodiments, a battery (e.g., disposable, rechargeable, etc.), an AC power source (e.g., with or without a transformer) or any other power device or source can be connected, attached or otherwise supplied to the desired component or subcomponent of the treatment system. In addition, the various components or subcomponents can include one or more controllers, electrical and/or instrumentation connections, ports and/or the like, as desired or required for the proper operation of the treatment system.


According to one embodiment, the self-contained handpiece assembly 310 illustrated in FIG. 7 is configured to include a rechargeable battery. The handpiece assembly 310 can be sized, shaped and otherwise configured to be placed in a docking station when not in use. The docking station can be configured to recharge the battery of the assembly 310. In other embodiments, however, a handpiece assembly can be powered by AC or DC power (e.g., connected to a power cable or the like).



FIG. 10 illustrates one embodiment of a cartridge 500 containing a serum and/or another fluid or material used during a skin treatment procedure. As shown, the cartridge 500 can comprise a membrane 504 or other member to seal or substantially seal the internal contents of the cartridge 500. In addition, the cartridge 500 can include a locking ear 506 or other feature or member that is configured to mate with a corresponding portion of the handpiece assembly. In some embodiments, such a locking ear 506 is sized, shaped and otherwise configured to align with a slot or other opening in a docking area of the handpiece assembly. Once the locking ear 506 or other feature is properly aligned with and pushed into a corresponding recess or other portion of the handpiece assembly, the cartridge 500 can be rotated or otherwise moved to secure it to the handpiece assembly. In other arrangements, a cartridge include two or more locking ears 506 or other features that are configured to mate with corresponding areas or portions of the handpiece assembly.


With further reference to FIG. 10, the cartridge 500 can include an O-ring 502 or other sealing member to help prevent fluids and/or other substances from leaking once the cartridge 500 is properly inserted within the handpiece assembly. In the illustrated embodiment, the cartridge 500 comprises a generally cylindrical body with a relatively narrow neck portion. However, it will be appreciated that the shape, size and/or any other details or characteristics of the cartridge 500 can be different than illustrated and discussed herein to suit a particular application or use.



FIG. 11 illustrates a cross-sectional view of a docking portion or area 510 of a handpiece assembly with a cartridge 500 being secured therein. As illustrated, the docking area 510 of the handpiece assembly can include a hollow tube 516 or other puncturing member that is configured to penetrate the membrane 504 when the cartridge 500 is securely positioned within the docking area 510. As discussed, in order to prevent or reduce the likelihood of leaks, the nozzle of the cartridge and/or the docking area 510 can comprise an O-ring 502 and/or another sealing member.


According to some embodiments, once the membrane 504 is punctured, the internal contents of the cartridge 500 can be in fluid communication with the tip (not shown) of a handpiece assembly. Thus, the hollow tube 516 or other penetrating member can access the internal contents of the cartridge 500 so they can be transferred through the body of the handpiece assembly to a working surface (e.g., tip). The fluids and/or other substances can be conveyed to a tip or other working surface of the handpiece assembly by gravity flow, using a pump or other fluid transfer device and/or the like. In some arrangements, as illustrated in FIG. 10, the cartridge 500 includes a locking member 506 (e.g., tab) that is configured to mate with a corresponding portion of the docking area 510 when properly inserted therein.


The membrane 504 of the cartridge 500 can include any flexible, semi-rigid or rigid materials that is adapted to be punctured by a hollow tube 516 or other member when the cartridge 500 is secured to a handpiece assembly. In some embodiments, the membrane comprises rubber, plastic and/or the like. In addition, the membrane 504 can be configured to be re-sealable once the cartridge 500 is removed from the handpiece assembly.



FIGS. 12-14 illustrate another embodiment of a handpiece assembly 600 adapted to treat the skin. The depicted assembly 600 comprises a main body portion 602, a working tip 604 and a docking area or port 605 in which a cartridge 610 and a waste canister 620 can be inserted. Such a handpiece assembly 600, as with other embodiments disclosed herein, can be an all-inclusive assembly that eliminates or reduces the need for other separate components. For example, the main body portion 602 can comprise a vacuum pump or other fluid transfer device (not shown) to help deliver fluids and other treatment materials to the working tip 604 and remove waste fluids, exfoliated skin and/or other materials to the waste canister 620.


With reference to FIG. 13, the handpiece assembly 600 can include a docking port or area 605 that is configured to receive a cartridge 610. The cartridge can include one or more treatment fluids, substances or the like. In some embodiments, as discussed herein with respect to the embodiment illustrated in FIG. 10, the cartridge 610 comprises a membrane (not shown in FIG. 13) that is configured to substantially seal the internal contents of the cartridge 610. The docking area 605 can include a puncturing member 606 (e.g., hollow tube, syringe, needle, etc.) that is sized, shaped, positioned and otherwise configured to break the membrane or seal so that the contents of the cartridge 610 can be placed in fluid communication with the main body portion 602 and the tip 604 of the handpiece assembly 600. The cartridge 610 and docking area 605 can include one or more mating features (e.g., threads, locking tabs, snap connections, other mechanical fasteners, etc.) to ensure that the cartridge 610 is secured to the handpiece assembly 600 during use.


As illustrated in the cutaway cross-sectional view of FIG. 13, the docking area 605 can be shaped, sized and otherwise configured to receive a nozzle 612 or other protruding member of the cartridge 610. Accordingly, the hollow tube 606 or other puncturing member of the main body portion 602 can penetrate a membrane or other sealing member disposed along the end of the nozzle 612 once the cartridge 610 is secured within the docking area 605. In order to prevent or reduce the likelihood of leaks of fluids and/or other substances contained within the cartridge 610, the nozzle 612 can comprise one or more O-rings 614 or other sealing members.


The handpiece assembly 600 illustrated in FIGS. 12-14 includes a generally rectangular shape. However, in other embodiments, the shape, size and/or other characteristics or properties of the handpiece assembly 600 can vary, as desired or required by a particular application or use.



FIG. 14 illustrates one embodiment of a waste canister 620 that is configured to attach to a proximal end of the handpiece assembly 600. The waste canister 620 can be configured to collect exfoliated skin, used serums and other fluids and/or the like that are drawn away from a person's skin during treatment. As shown, the waste canister 620 can comprise a port 622 that is adapted to engage and secure to one or more receiving areas of the main body portion 602 of the handpiece assembly 600. As with the cartridge 610, the waste canister 620 can include one or more mating features with the adjacent portion of the handpiece assembly 600. Further, one or more O-rings 622 or other sealing members can be used to prevent or reduce the likelihood of leaks between the waste canister 620 and the main body portion 602 of the handpiece assembly 600.


With continued reference to FIG. 12, the handpiece assembly can include a port 608 or other connection for a power source or other electrical connection. In some embodiments, the port 608 is configured to receive an AC adapter or transformer (e.g., 12 volt charger). In other embodiments, the handpiece assembly 600 comprises a rechargeable battery or other power source (not shown) which may be recharged via the port 608.



FIGS. 15-17 illustrate another embodiment of a handpiece assembly 700 that comprises, among other things, a main body portion 702, a working tip 704 and a docking area 705 for receiving a cartridge 720. As shown in FIG. 16, the cartridge 720 can comprise a locking ear 722 or other protruding member that is sized, shaped and otherwise configured to help mate and secure the cartridge 720 to the docking area 705. For example, the docking area 705 can include a recess 706 (e.g., turn lock feature) that is adapted to receive the locking ear 722 or other member of the cartridge 720. Once the cartridge 720 is aligned with and inserted into the recess 706, it can be rotated or otherwise moved to temporarily secure the cartridge 720 to the main body portion 702 of the assembly 700.


When the contents of the cartridge 720 have been emptied and/or when a user wishes to use fluids and/or materials contained with a different cartridge 720, the process by which the cartridge 720 was secured within the docking area 705 can be reversed. For example, the cartridge 720 can be rotated so that the locking ear 722 or other protruding member generally aligns with the recess 706 to permit the cartridge 720 to be removed. As with other embodiments, the illustrated cartridge 720 can include an O-ring 726 or other sealing member to prevent or reduce the likelihood of leaks.


With continued reference to FIGS. 15-17, for aesthetic, ease of handling and/or any other reason, the handpiece assembly 700 can include a tapered shape. As with any other embodiments disclosed herein, or variations thereof, the handpiece assembly 700 can be designed with finger grips or other features that facilitate a user to grip and manipulate the handpiece assembly 700 during use. In addition, the outer surface of any of the embodiments of the handpiece assemblies discussed and/or illustrated herein (or variations thereof) can comprise one or more durable materials that are configured to withstand the elements to which they may be exposed. In some embodiments, the exposed surfaces of a handpiece assembly comprise plastics, metals (e.g., stainless steel) and/or the like.


With continued reference to FIG. 17, the handpiece assembly 700 can be placed in fluid communication with a housing 740 and a waste canister 730 via one or more conduits 710. As shown, the housing 740 can receive a removable waste canister 730 along its upper surface. Alternatively, the housing 740 can be adapted to receive one or more waste canisters 730 at any other portion or location. In some embodiments, the canister 730 can be advantageously removed from the housing 740 for emptying, cleaning and/or any other purpose. As with other embodiments disclosed herein, the housing 740 can comprise an internal and/or external pump or other fluid transfer device. Such a fluid transfer device can be used to remove waste fluids and/or other materials away from the tip 704 of the handpiece assembly 700 (e.g., via a waste conduit 710), and in some arrangements, simultaneously draw treatment serums and other fluids from the canister 720 toward the tip 704 of the handpiece assembly 700.


The pump, other fluid transfer device and/or any other electric component or features of the system can be operated by one or more power sources (e.g., AC, DC, rechargeable or disposable batteries, etc.). In addition, the handpiece assembly 700 and/or the housing 740 can include buttons, dials and/or other members that permit a user to selectively control the operation during a treatment procedure.



FIGS. 18 and 19 illustrate another embodiment of a handpiece assembly 800 configured for use in a skin treatment system. Like in other embodiments disclosed herein, the depicted handpiece assembly 800 comprises a main body portion 802, a removable tip 810 and a receiving or docking area 805 for securely receiving a cartridge 820. As shown, the main body portion 802 of the handpiece assembly 800 can comprise a port 807 to which a conduit 830 or other channeling member may connect. According to some embodiments, the conduit 830 is placed in fluid communication with a vacuum pump or other fluid transfer device (not shown) for removing waste materials away from the treatment surface (e.g., tip 810).


As discussed herein in reference to other arrangements, the cartridge 820 can include a nozzle portion with a locking ear 826 or other protruding member that is configured to engage and mate with a corresponding slot 806, recess and/or other feature of the docking area 805. Further, the nozzle of the cartridge 820 can include an O-ring 828 or other sealing member to prevent or reduce the likelihood of leaks when fluids and/or other substances are being transferred from the cartridge 820 to the tip 810. In some embodiments, the end of the nozzle portion of the cartridge comprises a membrane or other member (not shown) that can be punctured or otherwise compromised by a hollow tube 808, spike or other member when the cartridge 820 is secured within the docking area 805.


Another embodiment of a skin treatment system 900 comprising a handpiece assembly 910, a replaceable cartridge 920 and a separate base member 940 is illustrated in FIG. 20A. As shown, the handpiece assembly 910 can comprise a main body portion 912 to which a cartridge 920 and a removable tip 970 can be secured. In addition, the handpiece assembly 910 can include a port 917 that is used to place the handpiece assembly 910 in fluid communication with the base member 940 via one or more conduits 930. As with other embodiments disclosed herein, the cartridge 920 can be selectively secured to and/or removed from the main body portion 912 of the handpiece assembly. Thus, the cartridge 920 can include one or more locking ears, O-rings and/or the like.


In addition, the base member 940 can include a waste canister or container 960 that is adapted to receive waste fluids and other substances. As with the cartridge 920, the waste canister 960 can be configured to be selectively secured to and/or removed from the base member 940 for emptying, cleaning, replacement and/or any other purpose.


Further, in some embodiments, the base member 940 comprises one or more controls (e.g., ON-OFF switches, other switches, knobs and/or the like) for regulating the operation of the system. As shown, a power supply or other electrical connection 950 can be used to power the base member 940, a vacuum pump or other fluid transfer device contained within the base member 940 (or any other portion of the system) and/or any other electrical component or subcomponent of the system. Further, the base member 940 can comprise a recessed area 946 along its lower portion which is configured to receive one or more conduits 930, power cables and/or the like.



FIGS. 20B and 20C illustrate different views of one embodiment of a removable tip 970 configured for placement on a handpiece assembly as disclosed herein. As shown, the tip 970 can include a tip body portion 973 and a tip skirt portion 972 extending along the bottom of the tip body portion 973. The skirt portion 972 can include a plurality of gripping members or other features (e.g., recesses, protrusions, etc.) to facilitate the handling of the tip 970.


A tip can be configured to slidably connect to the distal end and/or any other portion of a handpiece assembly. For example, in some embodiments, the tip can be press fit onto the handpiece assembly. One or more O-rings or other sealing members can be used between adjacent surfaces of the tip and the handpiece assembly to prevent or reduce the likelihood of undesirable leaks. In other embodiments, a tip can be secured to a handpiece assembly using any other method or device, such as, for example, a threaded connection, interlocking tabs, flanges or other members, other fasteners and/or the like. In still other arrangements, the tip can be permanently or semi-permanently attached to the handpiece assembly.


In the embodiment illustrated in FIGS. 20B and 20C, the tip 970 comprises one or more surfaces, elements and/or features along its distal end 971 that are configured to treat (e.g., exfoliate) skin. Such tips can include one or more treatment elements, either in addition to or in lieu of abrasive elements. As used herein, “abrasive element” is a broad term and includes, without limitation, protruding elements, abrasive materials (e.g., grit, sandpaper-like material, other coarse materials, etc.), roughened surfaces, contoured surfaces, surfaces with openings, recesses or other features, brushes, blades, surfaces impregnated with diamonds or other materials and/or the like. Further, as used herein, “treatment element” is a broad term and includes, without limitation, an abrasive element, massage elements or features, elements or features configured to moisturize or apply one or more treatment agents or fluids, polishing or soothing elements or features and/or the like. As discussed, any embodiments of a tip for a handpiece assembly can comprise one or more treatment elements and/or abrasive elements, as desired or required by a particular application.


As illustrated in FIGS. 20A and 20B, the tip 970 can include a lip 977 or other ridge member along its outer periphery. The lip member 977 can generally define the periphery of the distal end 971 of the tip 970. In some embodiments, when the tip 970 is positioned against the skin, the lip member 977 inhibits or substantially inhibits fluids or other materials from escaping a space generally defined between the tip 970 and the adjacent skin surface.


With continued reference to FIGS. 20B and 20C, the tip 970 can include a plurality of protruding members 980 positioned along its distal end 971 and within the interior of the lip member 977. The protruding members 980 can be posts or other cylindrically-shaped objects. In some embodiments, the protruding members 980 comprise relatively sharp edges, which can be configured to remove skin. The protruding members 980 can have relatively sharp planing blades. The plurality of protruding members 980 can ablate or roughen a plurality of smaller sections of the skin being treated.


As illustrated, the outer diameter or other comparable dimension (e.g., length, width, etc.) of the posts or other protruding members 980 can vary. In other arrangements, the diameter and/or other dimensions of the protruding members can be similar or substantiality similar. The posts or other protruding members 980 can be located, spaced and otherwise oriented along the distal end 971 of the tip 970 in any desired or required manner.


It will be appreciated that the size, shape, spacing, orientation, location and/or other properties of the protruding members 980 can be different than illustrated and disclosed herein, as desired or required by a particular procedure or application. As discussed herein, the lip member 977 of the tip 970 can help create an enclosed space generally defined between the distal end 971 of the tip 970 and the skin surface being treated. Therefore, according to some embodiments, the lip member 977 extends above the top of the protruding members 980 so that the protruding members are within the enclosed space during a treatment procedure. In other embodiments, the top surface of the lip 977 is generally aligned with the top surface of or below the protruding members 980.


With reference to FIGS. 20B and 20C, the tip 970 can include an interior delivery stem 974 that is configured to place the distal end 971 of the tip 970 in fluid communication with the one or more delivery channels or other conduits located within the handpiece assembly. For example, the delivery stem 974 can be sized, shaped and otherwise adapted to receive fluids and/or other materials from an internal delivery channel of the handpiece assembly.


As illustrated in FIGS. 20B and 20C, the distal end 971 of the tip 970 can include an opening 982 through which fluids and/or other materials conveyed by the delivery stem 974 may exit. As shown, the opening 982 can be located at or near the center of the distal end 971 of the tip 970. In other arrangements, a tip 970 can include additional stems 974 and/or openings 982. In addition, the size, shape, location and/or other details of the openings 982 can be different than illustrated herein.


Moreover, the distal end 971 of the tip 970 can include one or more outlet openings 984 through which exfoliated skin, spent serums, other waste liquids, fluids and other materials and/or the like can be removed. In the embodiment illustrated in FIGS. 20B and 20C, the tip 970 includes two outlet openings 984. However, more or fewer openings can be included, as desired or required. In addition, some or all of the posts or other protruding members 980 can be generally hollow so that they perform a similar function as other outlet openings 984 of the tip 970. In other embodiments, however, some or all of the protruding members 980 are not hollow or do not include openings therethrough.


In some embodiments, once the distal end 971 of a tip 970 is positioned against the skin being treated, an enclosed space can be created between the skin surface and tip, generally along the interior of a peripheral lip member or other ridge. Therefore, as a vacuum or another suction source is generated in the handpiece assembly, exfoliated skin, spent serum, other fluids and/or other materials can be removed away from the tip 970. At the same time, the delivery stem 974 of the tip 970 and any other conduit or space that is in fluid communication with it may also be subjected to a suction force. Consequently, serums, other fluids and/or other treatment materials can be advantageously transported to the distal end 971 of the tip 970 through one or more openings 982. As discussed, the tip 970 or variations thereof can comprise any combination of treatment elements and/or abrasive elements, as desired or required by a particular application.


Additional details regarding tips for any embodiments of a handpiece assembly disclosed herein can be found in U.S. patent application Ser. No. 11/392,348 (filed on Mar. 29, 2006 and published as U.S. Publication No. 2007/0156124) and U.S. Provisional Patent Application No. 61/024,504 (filed on Jan. 29, 2008), the entireties of both of which are hereby incorporated by reference herein.



FIG. 21 illustrates another embodiment of a handpiece assembly 1000. In some arrangements, the illustrated assembly 1000 may be particularly well-suited to be used as a shower model. For example, the tip 1020 of the handpiece assembly 1000 can include a dried serum or other material that is configured to dissolve when coming in contact with water and/or other fluids. Thus, once in contact with water, the tip 1020 can be operated to remove skin. For instance, water from a shower head can be used to dissolve the media situated on the tip 1020 of the handpiece assembly 1000. In some embodiments, the handpiece assembly 1000 comprises an internal vacuum pump or other fluid transfer device (not shown) that is used to draw waste liquid and/or materials away from the tip 1010 toward one or more drains 1040. Such drains 1040 may or may not be connected to a separate conduit or other collection device, as required or desired by a particular application.


With continued reference to FIG. 21, the handpiece assembly 1000 can comprise a main body portion 1002 that a user can grasp and manipulate during use. In addition, the tip 1020 can be adapted to be removably positioned onto a raised mounting portion 1010 of the handpiece assembly. In other embodiments, however, the tip 1020 attached directly to the main body portion 1002 of the assembly 1000.


As discussed herein with reference to FIGS. 20B and 20C, the tip 1020 can comprise an outer lip 1024 or other ridge member along its outer periphery. The lip member 1024 can generally define the periphery of the distal end of the tip 1020. In some embodiments, when the tip 1020 is positioned against skin, the lip member 1024 inhibits or substantially inhibits fluids or other materials from escaping a space generally defined between the tip 1020 and the adjacent skin surface. Further, the tip 1020 can include a plurality of protruding members 1030 positioned along its distal end and within the interior of the lip member 1024. As discussed, the protruding members 1030 can be posts or other cylindrically-shaped objects. In some embodiments, the protruding members 1030 comprise relatively sharp edges, which can be configured to remove skin. The protruding members 1030 can have relatively sharp planing blades. Further, the tip 1020 can include one or more openings 1032, 1034 through which treatment fluids, exfoliated skin, other waste materials and/or other substances may enter or exit the working surface of the tip 1020. The size, shape, quantity, location, spacing and/or other details of the openings 1032, 1034 can vary, as desired or required by a particular application or use.


In any of the embodiments disclosed herein, including the one illustrated in FIG. 21, the tip of the handpiece assembly can be configured to rotate, pivot, tilt and/or otherwise move, as desired or required by a particular application.



FIG. 22 illustrates a charger or docking station 1050 which can be sized, shaped and configured to receive a handpiece assembly. It will be appreciated that any other embodiments of a handpiece assembly disclosed herein can be configured to be placed and stored in such a docking station 1050. The station 1050 can include a cavity or other receiving area in which one or more portions of a handpiece assembly may be selectively inserted and removed. The station 1050 can be attached to a power cord 1070 or other power source so that a rechargeable battery located within the handpiece assembly can be charged.


Another embodiment of a skin treatment system 1100 comprising a handpiece assembly 1110, a base member 1130 and a waste cartridge 1140 is illustrated in FIGS. 23 and 24. As with other embodiments disclosed herein, the handpiece assembly 1110 can comprise a docking area in which a cartridge 1120 can be selectively removed or attached. In some arrangements, the handpiece assembly 1110 can be secured to a base member 1130 using one or more clips 1116, holders or other members. The handpiece assembly 1110 can be placed in fluid communication with a waste canister 1140 using one or more conduits 1150.


With continued reference to FIGS. 23 and 24, the waste canister 1140 can be configured to be selectively attached to and/or removed from the base member 1130 for emptying, cleaning and/or any other purpose. In some embodiments, the waste canister 1140 comprises a lid 1142 or other cover member. As with any other embodiments disclosed herein, the base member 1130 and/or the handpiece assembly 1110 can comprise one or more buttons 1132, 1134, dials and/or other control members to regulate the operation of the skin treatment system. In addition, the base member can include a recessed region 1136 can enables one or more fluid conduits 1150, power cables or other members to be conveniently coiled therearound. Further, the handpiece assembly 1110 can comprise a main body portion 1101 and a tip 1118 permanently or removably secured thereto.


According to another embodiment, a handpiece assembly can be configured to be used in a shower or in other wet or high moisture conditions. Thus, in some arrangements, the handpiece assembly is waterproof and/or water resistant. In such embodiments, the pump or other fluid transfer device can be driven by electrical power, by water pressure (e.g., one or more connections to running water), by pneumatic power and/or any other method or device. It will be appreciated that such alternative methods or devices of operating a pump or other fluid transfer device can be used with respect to any other embodiment disclosed herein.


Some or all of the embodiments disclosed herein can be particularly useful for less expensive and/or simpler microdermabrasion systems. In some embodiments, such systems can target the home consumer market.


In any of the embodiments described and/or illustrated herein, or variations thereof, treatment fluids and/or other materials can be delivered to the tip of a handpiece assembly using one or more ways. For example, in some embodiments, serums or other substances can be delivered through a supply canister or fluid bottle. Such serums, compositions, other fluids or substances can be pre mixed so that they are delivered to the tip and the skin unmodified or substantially unmodified.


In other embodiments, serums, fluids, gels or other materials can be in the form of a pack container dry granular material, viscous gels and/or the like. Such packs can be mixed with water or some other fluid by a user to a desired concentration. In other embodiments, one or more treatment materials can be impregnated or otherwise embedded into the tips of the handpiece assemblies. Thus, such materials (e.g., powers, solids, gels, etc.) can advantageously dissolve when they contact water, saline or some other liquid. In still other embodiments, the treatment materials can be contained within a capsule, tablet or other enclosure. Such enclosures can be configured to dissolve when placed in water or some other fluid. Therefore, in some embodiments, a user may be required to place a capsule, the contents of a pack or some other materials into a canister and add water or other fluid before use.


In some embodiments, one or more serums or other substances can be delivered to the treatment surface of a handpiece assembly to treat a particular skin condition. For example, the system can be used to treat acne, dry or oily skin, fine lines, sun-damaged skin, other skin diseases or disorders and/or like.


In some embodiments, the serums, other materials and/or a combination of such serums or other materials can be utilized for the treatment of substantially most or all skin types. For example, such serums and/or other materials can be used when the handpiece assembly exfoliates skin.


In another embodiment, the serums, other materials and/or a combination of such serums or other materials can be used during a follow-up (e.g., secondary, tertiary, etc.) or finish treatment step. For example, such serums and/or other materials can be used to hydrate the skin and/or lighten treat skin damage, either in lieu of or in addition to exfoliating skin. In such embodiments, the serums and/or other materials can comprise anti-oxidants, hyaluronic acid and/or the like.


In yet other embodiments, the serums, other materials and/or a combination of such serums or other materials can be used to target acne or oily skin conditions. It will be appreciated that other serums, other materials and/or combinations of such serums or other materials can be used to target one or more types of skin conditions or treatments. Further, a particular treatment procedure can utilize one, two or more of such serums or other materials during various treatment phases (e.g., exfoliation, finish or polishing treatment, etc.).


In some embodiments, one or more kits can be developed that target a specific type of user, skin condition, desired result and/or the like. For example, such a kit can comprise serums and/or other materials that target teenage acne. As discussed, the serums and/or other materials contained in such kits can be in one or more different forms, such as, for example, liquids, gels, other fluids, powders, solids and/or the like. In some embodiments, such serums and/or other materials can be configured for immediate use. Alternatively, a particular amount of water, saline or other liquids, other dilution or dissolving agents and/or the like may need to be added to the serums and/or other materials to get them to a usable state.


In addition, depending on who the target user is (e.g., teenagers, adults, etc.) and/or how severe a particular condition is, the concentration or strength of the serums and/or other materials can be varied. For example, for younger users, a kit directed at acne treatment can comprise lower concentrations of serums and/or other materials. By way of another example, kits comprising higher concentrations or strengths of serums and/or other materials can be used to treat oily skin or acne in adults. In another embodiment, a kit can be developed to target users whose skin is generally typical (e.g., the users' skin is not abnormally dry or oily, the users do not have excessive amount of acne or scarring, etc.).


As discussed, the kits can include one, two or more different types of treatment combinations. For example, a kit can comprise a first combination of serum(s) and/or other material(s) that is intended to target the exfoliation of skin. The same kit may include a second treatment combination that can be used in a follow-up treatment to treat oily skin or the like. In other embodiments, however, a kit can comprise more or fewer treatment combinations, as desired or required by a particular skin treatment procedure.


The articles, devices, assemblies, systems and/or other items disclosed herein may be formed through any suitable means. The various methods and techniques described above provide a number of ways to carry out the invention. Of course, it is to be understood that not necessarily all objectives or advantages described may be achieved in accordance with any particular embodiment described herein. Thus, for example, those skilled in the art will recognize that the methods may be performed in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other objectives or advantages as may be taught or suggested herein.


Furthermore, the skilled artisan will recognize the interchangeability of various features from different embodiments disclosed herein. Similarly, the various features and steps discussed above, as well as other known equivalents for each such feature or step, can be mixed and matched by one of ordinary skill in this art to perform methods in accordance with principles described herein. Additionally, the methods which are described and illustrated herein are not limited to the exact sequence of acts described, nor are they necessarily limited to the practice of all of the acts set forth. Other sequences of events or acts, or less than all of the events, or simultaneous occurrence of the events, may be utilized in practicing the embodiments of the invention.


Although the invention has been disclosed in the context of certain embodiments and examples, it will be understood by those skilled in the art that the invention extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses and obvious modifications and equivalents thereof. Accordingly, it is not intended that the invention be limited, except as by the appended claims.

Claims
  • 1. A skin abrasion system comprising: a handpiece assembly comprising a main body portion and a tip, wherein the tip is configured to contact skin tissue, wherein the tip is configured to be moved along skin tissue during use to remove at least a portion of a stratum corneum of the skin, wherein the tip is configured to secure to a distal end of the main body portion;a waste canister for collecting waste materials withdrawn from a treatment surface during a procedure, wherein the waste canister is configured to removably secure to a proximal end of the handpiece assembly, wherein the proximal end and a distal end of the handpiece assembly are located on opposite ends of the main body portion of the handpiece assembly;wherein the waste canister is physically attached to and incorporated into the handpiece assembly when the waste canister is secured to the main body portion along the proximal end of the handpiece assembly, the waste canister being configured to separate from the main body portion to discard waste materials collected in the waste canister;at least one fluid delivery passage positioned at least partially within the handpiece assembly and placing the tip in fluid communication with a fluid source; andat least one suction passage positioned at least partially within the handpiece assembly and placing the waste canister in fluid communication with the tip when the waste canister is secured to the handpiece assembly.
  • 2. The system of claim 1, wherein the tip is removably secured to the handpiece assembly.
  • 3. The system of claim 1, wherein the tip comprises at least one abrasive element, wherein the at least one abrasive element is configured to abrade skin tissue when the handpiece assembly is moved relative to the skin tissue.
  • 4. The system of claim 3, wherein the at least one abrasive element comprises at least one protruding member, the at least one protruding member comprising a sharp edge.
  • 5. The system of claim 1, wherein the fluid source comprises a supply canister configured to store a treatment fluid, and wherein the at least one delivery passage is configured to be placed in fluid communication with the supply canister.
  • 6. The system of claim 5, wherein the supply canister is configured to removably secure to the handpiece assembly.
  • 7. The system of claim 5, wherein the supply canister is configured to remain physically separated from the handpiece assembly.
  • 8. The system of claim 1, further comprising an electric fluid transfer device and a battery configured to electrically energize the electric fluid transfer device, wherein the electric fluid transfer device is configured to help move fluids and other materials through the at least one fluid delivery passage and/or through the at least one suction passage.
  • 9. The system of claim 8, wherein the handpiece assembly is configured to be positioned in a docking station when not in use, wherein the docking station is configured to recharge the battery when the handpiece assembly is positioned in the docking station.
  • 10. The system of claim 1, wherein the handpiece assembly comprises at least one controller that permits a user to selectively regulate operation of the system during a treatment procedure.
  • 11. A skin abrasion system comprising: a handpiece comprising a tip for contacting skin tissue; anda waste canister configured to removably secure to a proximal end of the handpiece, the waste canister configured to physically attach to and incorporate into the handpiece when the waste canister is secured to the proximal end of the handpiece assembly;wherein the tip is configured to remove at least a portion of a stratum corneum of the skin during use;wherein the tip is in fluid communication with the waste canister when the waste canister is secured to the handpiece;wherein the system is configured to transfer a treatment material from a fluid source to the tip;wherein the system is configured to transfer waste materials from a treatment surface to the waste canister for collecting waste materials during use; andwherein the waste canister is configured to separate from handpiece to discard waste materials collected in waste canister.
  • 12. The system of claim 11, wherein the tip is removably secured to the handpiece.
  • 13. The system of claim 11, wherein the tip comprises at least one abrasive element to abrade skin tissue when the handpiece is moved relative to skin tissue.
  • 14. The system of claim 13, wherein the at least one abrasive element comprises at least one sharp edge.
  • 15. The system of claim 11, wherein the fluid source comprises a supply canister configured to store a treatment fluid.
  • 16. The system of claim 15, wherein the supply canister is configured to removably secure to the handpiece.
  • 17. The system of claim 15, wherein the supply canister is configured to remain physically separated from the handpiece yet in fluid communication with the tip.
  • 18. The system of claim 11, further comprising an electric fluid transfer device and a battery configured to electrically energize the electric fluid transfer device, wherein the electric fluid transfer device is configured to help move fluids to and/or from the tip.
  • 19. The system of claim 18, wherein the handpiece is configured to be positioned in a docking station when not in use, wherein the docking station is configured to recharge the battery when the handpiece is positioned in the docking station.
  • 20. The system of claim 11, wherein the handpiece comprises at least one controller that permits a user to selectively regulate operation of the system during a treatment procedure.
  • 21. A skin abrasion system comprising: a handpiece comprising a tip for contacting skin tissue; anda waste canister configured to removably secure along a proximal end of the handpiece, the waste canister configured to physically attach to and incorporate into the handpiece when the waste canister is secured to the proximal end of the handpiece assembly;wherein the tip is in fluid communication with the waste canister when the waste canister is secured to the handpiece; andwherein the system is configured to transfer waste materials from a treatment surface to the waste canister for collecting waste materials during use.
  • 22. The system of claim 21, wherein the system is configured to transfer a treatment material from a fluid source to the tip during use.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/344,357 filed Nov. 4, 2016, which is a continuation of U.S. patent application Ser. No. 13/620,376 filed Sep. 14, 2012 and issued on Nov. 8, 2016 as U.S. Pat. No. 9,486,615, which is a continuation of U.S. patent application Ser. No. 12/346,582 filed Dec. 30, 2008 and issued on Jan. 1, 2013 as U.S. Pat. No. 8,343,116, which claims the priority benefit under 35 U.S.C. § 119(e) of U.S. Provisional Application No. 61/019,196 filed Jan. 4, 2008 and U.S. Provisional Application No. 61/022,201 filed Jan. 18, 2008. The entireties of all of the foregoing are hereby incorporated by reference herein.

US Referenced Citations (1032)
Number Name Date Kind
1651585 Clair Dec 1927 A
D117295 Smith Oct 1939 S
D151807 Berkowitz Nov 1948 S
2608032 Garver Aug 1952 A
2631583 Lavergne Mar 1953 A
2701559 Cooper Feb 1955 A
2712823 Kurtin Jul 1955 A
2867214 Wilson Jan 1959 A
2881763 Robbins Apr 1959 A
2921585 Schumann Jan 1960 A
3037509 Schutz Jun 1962 A
3085573 Meyer et al. Apr 1963 A
3214869 Stryker Nov 1965 A
3468079 Kaufman Sep 1969 A
3476112 Elstein Nov 1969 A
3481677 Abrahamson Dec 1969 A
3505993 Lewes et al. Apr 1970 A
3560100 Spatz Feb 1971 A
3574239 Sollerud Apr 1971 A
3608553 Balamuth Sep 1971 A
3715838 Young et al. Feb 1973 A
3865352 Nelson et al. Feb 1975 A
3866264 Engquist Feb 1975 A
D237776 Arassa et al. Nov 1975 S
D237863 Peters et al. Dec 1975 S
3930598 Slagle Jan 1976 A
3948265 Al Ani Apr 1976 A
3964212 Karden Jun 1976 A
3968789 Simoncini Jul 1976 A
3977084 Sloan Aug 1976 A
4121388 Wilson Oct 1978 A
4155721 Fletcher May 1979 A
4170821 Booth Oct 1979 A
4182329 Smit et al. Jan 1980 A
4203431 Abura et al. May 1980 A
D255325 Hoyt Jun 1980 S
4216233 Stein Aug 1980 A
4225254 Holberg et al. Sep 1980 A
D258348 Hoyt Feb 1981 S
D259921 Hartmann Jul 1981 S
D260176 Boschetti et al. Aug 1981 S
4289158 Nehring Sep 1981 A
4299219 Norris, Jr. Nov 1981 A
4342522 Mackles Aug 1982 A
4378804 Cortese Apr 1983 A
4500222 Clading-Boel Feb 1985 A
4560373 Sugino et al. Dec 1985 A
D288293 Arvans Feb 1987 S
4646480 Williams Mar 1987 A
4646482 Chitjian Mar 1987 A
4655743 Hyde Apr 1987 A
4671412 Gatten Jun 1987 A
4676749 Mabille Jun 1987 A
D290999 Novak Jul 1987 S
4706676 Peck Nov 1987 A
4718467 Di Gianfilippo et al. Jan 1988 A
4754756 Shelanski Jul 1988 A
4757814 Wang et al. Jul 1988 A
4764362 Barchas Aug 1988 A
4795421 Blasius, Jr. et al. Jan 1989 A
4811734 McGurk-Burleson et al. Mar 1989 A
4836192 Abbate Jun 1989 A
4866202 Weil Sep 1989 A
4875287 Creasy et al. Oct 1989 A
4886078 Shiffman Dec 1989 A
4887994 Bedford Dec 1989 A
4900316 Yamamoto Feb 1990 A
4917086 Feltovich et al. Apr 1990 A
4925450 Imonti et al. May 1990 A
D308480 Hoyt Jun 1990 S
4940350 Kim Jul 1990 A
4957747 Stiefel Sep 1990 A
4990841 Elder Feb 1991 A
5006004 Dirksing et al. Apr 1991 A
5006339 Bargery et al. Apr 1991 A
5012797 Clarke May 1991 A
D317719 Hestehave et al. Jun 1991 S
5035089 Tillman et al. Jul 1991 A
5037431 Summers et al. Aug 1991 A
5037432 Molinari Aug 1991 A
5054339 Yacowitz Oct 1991 A
5100412 Rosso Mar 1992 A
5100424 Jang Mar 1992 A
5119839 Rudolph Jun 1992 A
5122153 Harrel Jun 1992 A
5171215 Flanagan Dec 1992 A
5192269 Poli et al. Mar 1993 A
5207234 Rosso May 1993 A
5217455 Tan Jun 1993 A
5222956 Waldron Jun 1993 A
5242433 Smith et al. Sep 1993 A
5254109 Smith et al. Oct 1993 A
5290273 Tan Mar 1994 A
5368581 Smith et al. Nov 1994 A
5387215 Fisher Feb 1995 A
5391151 Wilmot Feb 1995 A
5417674 Smith et al. May 1995 A
5419772 Teitz et al. May 1995 A
5423803 Tankovich et al. Jun 1995 A
5437372 Per-Lee Aug 1995 A
5441490 Svedman Aug 1995 A
5460620 Smith et al. Oct 1995 A
5470323 Smith et al. Nov 1995 A
5484427 Gibbons Jan 1996 A
5490736 Haber et al. Feb 1996 A
5512044 Duer Apr 1996 A
5562642 Smith et al. Oct 1996 A
5562643 Johnson Oct 1996 A
5611687 Wagner Mar 1997 A
5612797 Clarke Mar 1997 A
5618275 Bock Apr 1997 A
5626631 Eckhouse May 1997 A
5658323 Miller Aug 1997 A
5658583 Zhang et al. Aug 1997 A
5674235 Parisi Oct 1997 A
5676643 Cann et al. Oct 1997 A
5676648 Henley Oct 1997 A
5683971 Rose et al. Nov 1997 A
5697920 Gibbons Dec 1997 A
5707383 Bays Jan 1998 A
5713785 Nishio Feb 1998 A
5735833 Olson Apr 1998 A
5755751 Eckhouse May 1998 A
5759185 Grinberg Jun 1998 A
5762640 Kajiwara et al. Jun 1998 A
5779519 Oliver Jul 1998 A
5800446 Banuchi Sep 1998 A
5807353 Schmitz Sep 1998 A
5810842 Di Fiore et al. Sep 1998 A
5813416 Rudolph Sep 1998 A
5817050 Klein Oct 1998 A
5817089 Tankovich et al. Oct 1998 A
5834510 Yu et al. Nov 1998 A
5846215 Zygmont Dec 1998 A
5848998 Marasco, Jr. Dec 1998 A
5857995 Thomas et al. Jan 1999 A
5861142 Schick Jan 1999 A
5873881 McEwen et al. Feb 1999 A
5879323 Henley Mar 1999 A
5879376 Miller Mar 1999 A
5882201 Salem Mar 1999 A
5885260 Mehl, Sr. et al. Mar 1999 A
5908401 Henley Jun 1999 A
5911223 Weaver et al. Jun 1999 A
5919152 Zygmont Jul 1999 A
5919479 Zhang et al. Jul 1999 A
5954730 Bernabei Sep 1999 A
5971999 Naldoni Oct 1999 A
5980555 Barbut et al. Nov 1999 A
6019749 Fields et al. Feb 2000 A
6023639 Hakky et al. Feb 2000 A
6024733 Eggers et al. Feb 2000 A
6027402 Oliver Feb 2000 A
6027495 Miller Feb 2000 A
6032071 Binder Feb 2000 A
6036684 Tankovich et al. Mar 2000 A
6039745 Di Fiore et al. Mar 2000 A
6042552 Cornier Mar 2000 A
6074382 Asah et al. Jun 2000 A
6080165 DeJacma Jun 2000 A
6080166 McEwen et al. Jun 2000 A
D428142 Stromblad Jul 2000 S
6090085 Mehl, Sr. et al. Jul 2000 A
6093021 Rainey Jul 2000 A
6113559 Klopotek Sep 2000 A
6120512 Bernabei Sep 2000 A
6129701 Cimino Oct 2000 A
6136008 Becker et al. Oct 2000 A
6139553 Dotan Oct 2000 A
6139554 Karkar et al. Oct 2000 A
6142155 Rudolph Nov 2000 A
6149634 Bernabei Nov 2000 A
6149644 Xie Nov 2000 A
6159226 Kim Dec 2000 A
6162218 Elbrecht et al. Dec 2000 A
6162232 Shadduck Dec 2000 A
6165059 Parkin et al. Dec 2000 A
6174325 Eckhouse Jan 2001 B1
6176198 Kao et al. Jan 2001 B1
6183451 Mehl, Sr. et al. Feb 2001 B1
6183483 Chang Feb 2001 B1
6190376 Asah et al. Feb 2001 B1
6193589 Khalaj Feb 2001 B1
6196982 Ball Mar 2001 B1
6231593 Meserol May 2001 B1
6235039 Parkin et al. May 2001 B1
6238275 Metcalf et al. May 2001 B1
6245347 Zhang et al. Jun 2001 B1
6264666 Coleman et al. Jul 2001 B1
6269271 Bernabei Jul 2001 B1
6277116 Utely et al. Aug 2001 B1
6277128 Muldner Aug 2001 B1
6280438 Eckhouse et al. Aug 2001 B1
6283978 Cheski et al. Sep 2001 B1
6284266 Zhang et al. Sep 2001 B1
6299620 Shadduck Oct 2001 B1
6306119 Weber et al. Oct 2001 B1
6306147 Bernabei et al. Oct 2001 B1
6322548 Payne et al. Nov 2001 B1
6322568 Bernabei et al. Nov 2001 B1
6325381 von Engelbrechten Dec 2001 B1
6325769 Klopotek Dec 2001 B1
6332886 Green et al. Dec 2001 B1
6334074 Spertell Dec 2001 B1
6355054 Neuberger Mar 2002 B1
6368333 Bernabei et al. Apr 2002 B2
6383177 Balle-Petersen et al. May 2002 B1
6387089 Kreindel et al. May 2002 B1
6387103 Shadduck May 2002 B2
6401289 Herbert Jun 2002 B1
6409736 Bernabei Jun 2002 B1
6410599 Johnson Jun 2002 B1
RE37796 Henley Jul 2002 E
6414032 Johnson Jul 2002 B1
6420431 Johnson Jul 2002 B1
6423078 Bays et al. Jul 2002 B1
6423750 Johnson Jul 2002 B1
6432113 Parkin et al. Aug 2002 B1
6432114 Rosso Aug 2002 B1
6458109 Henley et al. Oct 2002 B1
6471712 Burres Oct 2002 B2
6477410 Henley et al. Nov 2002 B1
6482212 Bernabei et al. Nov 2002 B1
6488646 Zygmont Dec 2002 B1
6494856 Zygmont Dec 2002 B1
6500183 Waldron Dec 2002 B1
6503256 Parkin et al. Jan 2003 B2
6508813 Altshuler Jan 2003 B1
6511486 Mercier et al. Jan 2003 B2
6514243 Eckhouse et al. Feb 2003 B1
6514262 Di Fiore et al. Feb 2003 B1
6514278 Hibst et al. Feb 2003 B1
6518538 Bernabei Feb 2003 B2
6520931 Suh Feb 2003 B2
D472136 Hermann Mar 2003 S
6527716 Eppstein Mar 2003 B1
6527783 Ignon Mar 2003 B1
6533776 Asah et al. Mar 2003 B2
6535761 Bernabei Mar 2003 B2
6537242 Palmer Mar 2003 B1
6540757 Hruska et al. Apr 2003 B1
6546281 Zhang et al. Apr 2003 B1
6562013 Marasco, Jr. May 2003 B1
6562050 Owen May 2003 B1
6564093 Ostrow et al. May 2003 B1
6565535 Zaias et al. May 2003 B2
6569157 Shain et al. May 2003 B1
6582442 Simon et al. Jun 2003 B2
6587730 Bernabei Jul 2003 B2
6589218 Garcia Jul 2003 B2
6592595 Mallett et al. Jul 2003 B1
6595934 Hissong et al. Jul 2003 B1
6611706 Avrahami et al. Aug 2003 B2
6626445 Murphy et al. Sep 2003 B2
6629927 Mesaros et al. Oct 2003 B1
6629971 McDaniel Oct 2003 B2
6629974 Penny et al. Oct 2003 B2
6629983 Ignon Oct 2003 B1
6635035 Marasco et al. Oct 2003 B1
6641591 Shadduck Nov 2003 B1
6645184 Zelickson et al. Nov 2003 B1
6652888 Rhoades Nov 2003 B2
6666874 Heitzmann et al. Dec 2003 B2
6673081 Tavger et al. Jan 2004 B1
6673082 Mallett et al. Jan 2004 B2
D486915 Warschewske et al. Feb 2004 S
6685853 Angelopoulous et al. Feb 2004 B1
6687537 Bernabei Feb 2004 B2
6689380 Marchitto et al. Feb 2004 B1
6695853 Karasiuk Feb 2004 B2
6699237 Weber et al. Mar 2004 B2
6712805 Weimann Mar 2004 B2
6726673 Zhang et al. Apr 2004 B1
D490561 Angeletta May 2004 S
6735470 Henley et al. May 2004 B2
6743211 Prausnitz et al. Jun 2004 B1
6743215 Bernabei Jun 2004 B2
6764493 Weber et al. Jul 2004 B1
6780426 Zhang et al. Aug 2004 B2
D496101 Davison Sep 2004 S
6800083 Hiblar et al. Oct 2004 B2
6800849 Staats Oct 2004 B2
D499207 Angeletta Nov 2004 S
D499841 Angeletta Dec 2004 S
D502288 Longoria Feb 2005 S
D502289 Longoria Feb 2005 S
D502569 Longoria Mar 2005 S
6869611 Kligman et al. Mar 2005 B1
6878144 Altshuler et al. Apr 2005 B2
6887260 McDaniel May 2005 B1
6905487 Zimmerman Jun 2005 B2
6911031 Muldner Jun 2005 B2
6926681 Ramey et al. Aug 2005 B1
6938805 Brincat Sep 2005 B2
6942649 Ignon et al. Sep 2005 B2
6960206 Keane Nov 2005 B2
6980448 Foss et al. Dec 2005 B2
7001355 Nunomura et al. Feb 2006 B2
7004933 McDaniel Feb 2006 B2
D517699 Lansohn Mar 2006 S
7031805 Lee et al. Apr 2006 B2
7044938 La Bianco et al. May 2006 B2
7051907 Brincat May 2006 B2
7052503 Bernabei May 2006 B2
D522360 Caserta et al. Jun 2006 S
7062317 Avrahami et al. Jun 2006 B2
7069073 Henley et al. Jun 2006 B2
7070488 Suissa et al. Jul 2006 B2
7083580 Bernabei Aug 2006 B2
7087036 Busby et al. Aug 2006 B2
7087063 Carson et al. Aug 2006 B2
7094252 Koop Aug 2006 B2
7108689 Eckhouse et al. Sep 2006 B2
7115275 Clarot et al. Oct 2006 B2
7118563 Weckwerth et al. Oct 2006 B2
7122029 Koop et al. Oct 2006 B2
7135011 Powers et al. Nov 2006 B2
D533962 Angeletta Dec 2006 S
7153311 Chung Dec 2006 B2
7166086 Haider et al. Jan 2007 B2
D536481 Angeletta Feb 2007 S
7172572 Diamond et al. Feb 2007 B2
7189230 Knowlton Mar 2007 B2
7197359 Tokudome et al. Mar 2007 B1
7198623 Fischer et al. Apr 2007 B2
7201765 McDaniel Apr 2007 B2
D545207 De Baschmakoff Jun 2007 S
7232431 Weimann Jun 2007 B1
7232444 Chang Jun 2007 B2
7241208 Suissa et al. Jul 2007 B2
7250045 Island et al. Jul 2007 B2
D553005 Py et al. Oct 2007 S
7276051 Henley et al. Oct 2007 B1
7293930 Chuang Nov 2007 B2
D557611 Ingemarsson Dec 2007 S
7314326 Rosenberg Jan 2008 B2
7316657 Kleinhenz et al. Jan 2008 B2
7316671 Lastovich et al. Jan 2008 B2
7318828 Revivo Jan 2008 B1
7320691 Pilcher et al. Jan 2008 B2
7320801 Kelly Jan 2008 B2
7326199 MacFarland et al. Feb 2008 B2
7329252 Yamazaki et al. Feb 2008 B1
7354423 Zelickson et al. Apr 2008 B2
7364565 Freeman Apr 2008 B2
7367981 Bernaz May 2008 B2
7384405 Rhoades Jun 2008 B2
7422567 Lastovich et al. Sep 2008 B2
7427273 Mitsui Sep 2008 B2
7440798 Redding, Jr. Oct 2008 B2
7458944 Liste et al. Dec 2008 B2
D584151 Murphy Jan 2009 S
7476205 Erdmann Jan 2009 B2
7477938 Sun et al. Jan 2009 B2
7482314 Grimes et al. Jan 2009 B2
7485125 Sjostrom Feb 2009 B2
7489989 Sukhanov et al. Feb 2009 B2
7494503 McDaniel Feb 2009 B2
7507228 Sun et al. Mar 2009 B2
7572238 Rhoades Aug 2009 B2
7582067 Van Acker Sep 2009 B2
7597900 Zimmer et al. Oct 2009 B2
7597901 Clarot et al. Oct 2009 B2
7607972 Groman Oct 2009 B2
7658742 Karasiuk Feb 2010 B2
7678120 Shadduck Mar 2010 B2
7730979 Kahrig Jun 2010 B2
7731570 Groman Jun 2010 B2
7740651 Barak et al. Jun 2010 B2
7744582 Sadowski et al. Jun 2010 B2
7749260 Da Silva et al. Jul 2010 B2
7758537 Brunell et al. Jul 2010 B1
7771374 Slatkine Aug 2010 B2
7780652 MacFarland et al. Aug 2010 B2
7789886 Shadduck Sep 2010 B2
D625198 Hall Oct 2010 S
7814915 Davenport et al. Oct 2010 B2
7837695 Hart et al. Nov 2010 B2
7857806 Karpowicz et al. Dec 2010 B2
7862564 Goble Jan 2011 B2
7901373 Tavger Mar 2011 B2
7927188 Groman Apr 2011 B2
7951156 Karasiuk May 2011 B2
D639164 Walsh Jun 2011 S
7981111 Grove et al. Jul 2011 B2
7981112 Neev Jul 2011 B1
7993333 Oral et al. Aug 2011 B2
8025669 David et al. Sep 2011 B1
RE42960 Waldron Nov 2011 E
8048064 Hwang et al. Nov 2011 B2
8048089 Ignon et al. Nov 2011 B2
8066716 Shadduck Nov 2011 B2
8088085 Thiebaut et al. Jan 2012 B2
8105295 Blott et al. Jan 2012 B2
8128638 Karasiuk et al. Mar 2012 B2
8135475 Kreindel et al. Mar 2012 B2
8182473 Altshuler et al. May 2012 B2
D664254 Yokoyama et al. Jul 2012 S
8221437 Waldron et al. Jul 2012 B2
8226663 Remsburg et al. Jul 2012 B2
8231292 Rabe et al. Jul 2012 B2
8236008 Boone, III et al. Aug 2012 B2
8236036 Frost Aug 2012 B1
8241094 Groman Aug 2012 B2
8273080 Mehta Sep 2012 B2
8276592 Davenport et al. Oct 2012 B2
8277287 Hart Oct 2012 B2
8282630 Neev Oct 2012 B2
8313480 Neev Nov 2012 B2
8317781 Owens et al. Nov 2012 B2
8323253 Hantash et al. Dec 2012 B2
8337513 Shadduck Dec 2012 B2
8343116 Ignon et al. Jan 2013 B2
8360826 Groman Jan 2013 B2
D676764 Moore et al. Feb 2013 S
D678783 Wilcox et al. Mar 2013 S
8398621 Beerwerth et al. Mar 2013 B2
D680437 Bartolo et al. Apr 2013 S
8430104 Hennings et al. Apr 2013 B2
8435234 Chan et al. May 2013 B2
8475507 Dewey et al. Jul 2013 B2
8478396 Tsao et al. Jul 2013 B2
8480721 Owens et al. Jul 2013 B2
8496654 Adanny et al. Jul 2013 B2
8496695 Kang et al. Jul 2013 B2
8535299 Giovannoli Sep 2013 B2
8545419 Kim Oct 2013 B2
8545489 Giovannoli Oct 2013 B2
8551104 Weckwerth et al. Oct 2013 B2
8562626 Sabir et al. Oct 2013 B2
8573874 Neuner Nov 2013 B2
8579916 Cheney Nov 2013 B2
8597284 Castro Dec 2013 B2
D697404 Johnson et al. Jan 2014 S
8632378 Groman Jan 2014 B2
8656931 Davenport et al. Feb 2014 B2
8668552 Groman Mar 2014 B2
8679039 Tieu et al. Mar 2014 B2
8700176 Azar et al. Apr 2014 B2
8702691 Weber et al. Apr 2014 B2
8702771 Frost Apr 2014 B1
8721662 Karasiuk May 2014 B2
8728064 Schomacker et al. May 2014 B2
8740917 Pilcher et al. Jun 2014 B2
D709617 Iliesco de Grimaldi et al. Jul 2014 S
8814836 Ignon et al. Aug 2014 B2
8818500 Duquet et al. Aug 2014 B2
8821940 Harris et al. Sep 2014 B2
8834933 Harris et al. Sep 2014 B2
8858570 Chang Oct 2014 B2
8939669 Le et al. Jan 2015 B2
D722172 Amemiya et al. Feb 2015 S
8945104 Boone, III et al. Feb 2015 B2
8945109 Mehta Feb 2015 B2
8974442 Boss, Jr. Mar 2015 B1
9017391 McDaniel Apr 2015 B2
9017392 Owens et al. Apr 2015 B2
9044582 Chang et al. Jun 2015 B2
9050133 Boone, III et al. Jun 2015 B1
9050156 Groman Jun 2015 B2
9056193 Ignon et al. Jun 2015 B2
D734154 Johnson et al. Jul 2015 S
9072521 Levi et al. Jul 2015 B2
9072533 Liu et al. Jul 2015 B2
9072892 Owens et al. Jul 2015 B2
9084587 Eckhouse et al. Jul 2015 B2
9149322 Knowlton Oct 2015 B2
D743269 Pape Nov 2015 S
D743558 Kim et al. Nov 2015 S
9186490 Chang et al. Nov 2015 B2
9227044 Bansal et al. Jan 2016 B2
9227082 McDaniel Jan 2016 B2
9233207 Polyakov et al. Jan 2016 B2
9271755 Luzon et al. Mar 2016 B2
9278230 Levin et al. Mar 2016 B2
9283037 Bragagna et al. Mar 2016 B2
9314302 Dougal Apr 2016 B2
9351792 Manstein et al. May 2016 B2
9351794 Suckewer et al. May 2016 B2
9375281 Moench et al. Jun 2016 B2
9421260 Harris et al. Aug 2016 B2
9421261 Harris et al. Aug 2016 B2
D765512 Joulia Sep 2016 S
9439964 Harris et al. Sep 2016 B2
9440093 Homer Sep 2016 B2
9452013 Manstein Sep 2016 B2
9468464 Shadduck Oct 2016 B2
9474886 Ignon et al. Oct 2016 B2
D772481 Paquet Nov 2016 S
9480836 Na Nov 2016 B2
9486615 Ignon et al. Nov 2016 B2
9498610 Ignon et al. Nov 2016 B2
9517085 Karasiuk Dec 2016 B2
9522287 Owens et al. Dec 2016 B2
9550052 Ignon et al. Jan 2017 B2
9566088 Ignon et al. Feb 2017 B2
9566454 Barthe et al. Feb 2017 B2
9572880 Harris et al. Feb 2017 B2
9597527 Buchholz et al. Mar 2017 B2
D782881 Seiders et al. Apr 2017 S
D787054 Rini et al. May 2017 S
9636521 Isserow et al. May 2017 B2
9636522 Oversluizen et al. May 2017 B2
9642997 Ignon et al. May 2017 B2
9662482 Ignon et al. May 2017 B2
9669233 Quisenberry et al. Jun 2017 B2
9675817 Isserow et al. Jun 2017 B2
9694199 Duquet et al. Jul 2017 B2
9700684 Vlodaver et al. Jul 2017 B2
9731053 Alai Aug 2017 B2
9744315 Levi Aug 2017 B1
9775645 Boone, III Oct 2017 B2
9775646 Shadduck Oct 2017 B2
9775976 Grez Oct 2017 B2
9814485 Pratt et al. Nov 2017 B2
9814647 Ajiki Nov 2017 B2
9814868 Ignon et al. Nov 2017 B2
9814906 McDaniel Nov 2017 B2
9833261 Boone, III et al. Dec 2017 B2
9861442 Tankovich et al. Jan 2018 B2
D811225 Newson Feb 2018 S
D811381 Morohoshi et al. Feb 2018 S
9918727 Boone, III et al. Mar 2018 B1
9949552 Rabe et al. Apr 2018 B2
9950147 Mehta Apr 2018 B2
9955769 Rabe et al. May 2018 B2
9962220 Domankevitz May 2018 B2
9968800 Anderson et al. May 2018 B2
10004919 Lemmens et al. Jun 2018 B2
D822845 Shimobayashi et al. Jul 2018 S
10010445 Isserow et al. Jul 2018 B2
10022289 Ajiki et al. Jul 2018 B2
10035007 Ignon et al. Jul 2018 B2
D825763 Lim et al. Aug 2018 S
10052467 Bansal et al. Aug 2018 B2
10076354 Knowlton Sep 2018 B2
10076646 Casasanta, III et al. Sep 2018 B2
10080581 Knowlton Sep 2018 B2
10092478 Amit Oct 2018 B1
10105191 Blanco et al. Oct 2018 B2
D833283 Rock Nov 2018 S
10130390 Hart et al. Nov 2018 B1
10130827 Buchholz et al. Nov 2018 B2
D836781 Meurer et al. Dec 2018 S
10149969 Grez et al. Dec 2018 B2
10149984 Modi et al. Dec 2018 B2
10172644 Ignon et al. Jan 2019 B2
10179229 Ignon et al. Jan 2019 B2
10183183 Burdette Jan 2019 B2
10188193 Rabe et al. Jan 2019 B2
10206743 Tankovich et al. Feb 2019 B2
10207034 Collins Feb 2019 B2
10220122 Clark, III et al. Mar 2019 B2
10238812 Ignon Mar 2019 B2
10238849 Britva et al. Mar 2019 B2
10251675 Ignon et al. Apr 2019 B2
10252044 Bock Apr 2019 B2
10271900 Marchitto et al. Apr 2019 B2
10272258 Quisenberry et al. Apr 2019 B2
D851759 Jones et al. Jun 2019 S
10307330 Sedic Jun 2019 B1
10308378 Goodwin et al. Jun 2019 B2
10314378 Rabe et al. Jun 2019 B2
10321948 Knowlton Jun 2019 B2
10328277 Modi et al. Jun 2019 B2
D852962 Chang Jul 2019 S
10335191 Knowlton Jul 2019 B2
10357641 Ignon et al. Jul 2019 B2
10357642 Ignon et al. Jul 2019 B2
10334933 Rosario et al. Aug 2019 B2
10369073 Rosario et al. Aug 2019 B2
10413359 Felsenstein et al. Sep 2019 B2
D861913 Stamm et al. Oct 2019 S
10456197 Felsenstein et al. Oct 2019 B2
10456321 Shadduck Oct 2019 B2
10456567 Streeter Oct 2019 B2
D867587 Holtz Nov 2019 S
10463429 Deem et al. Nov 2019 B2
10471274 Liu et al. Nov 2019 B2
10485983 Boone, III et al. Nov 2019 B1
D868981 Salamon et al. Dec 2019 S
D873430 Accolla Jan 2020 S
D873481 Larkin Jan 2020 S
10524835 Shadduck et al. Jan 2020 B2
10537304 Barthe et al. Jan 2020 B2
10537640 Harris et al. Jan 2020 B2
10556096 Ignon et al. Feb 2020 B2
10556097 Ignon et al. Feb 2020 B2
10583037 Isserow et al. Mar 2020 B2
D886370 Soutelo Gomes Jun 2020 S
D886372 Weinrich Jun 2020 S
D887571 Liu Jun 2020 S
10667985 Decaux et al. Jun 2020 B2
10675481 Tankovich Jun 2020 B1
10688290 Yuval Jun 2020 B1
10702328 Slatkine et al. Jul 2020 B2
10716924 Knowlton Jul 2020 B2
D893024 Whiteside Aug 2020 S
10736653 Knowlton Aug 2020 B2
10737080 Patterson Aug 2020 B2
10758261 Richardson Sep 2020 B2
10772658 Knowlton Sep 2020 B2
10792382 Rafko Oct 2020 B2
10799285 Mulholland Oct 2020 B2
10799430 Danto Oct 2020 B2
10813694 Johnson et al. Oct 2020 B2
10835287 Shadduck et al. Nov 2020 B2
10835726 Redding, Jr. Nov 2020 B2
10850095 Ebbers et al. Dec 2020 B2
10856900 Knowlton Dec 2020 B2
10860026 Nguyen et al. Dec 2020 B2
10874579 Rembert Dec 2020 B1
D908282 Kim Jan 2021 S
10893907 Kim Jan 2021 B2
10912428 Daffer Feb 2021 B2
10918190 Laudati Feb 2021 B2
10946191 Cazares Delgadillo Mar 2021 B2
10952811 Blanco et al. Mar 2021 B2
10952907 Carver Mar 2021 B1
D917290 Bravman et al. Apr 2021 S
10980592 Horton et al. Apr 2021 B2
10993743 Ignon et al. May 2021 B2
11020577 Ignon et al. Jun 2021 B2
11045661 Oversluizen et al. Jun 2021 B2
D927008 Rappaport Aug 2021 S
D928977 Dijkstra Aug 2021 S
11083515 Slatkine et al. Aug 2021 B2
11123039 Barthe et al. Sep 2021 B2
11141761 Connelly et al. Oct 2021 B2
11154723 Lee Oct 2021 B2
11172978 Wootten et al. Nov 2021 B2
11202657 Ignon et al. Dec 2021 B2
11213321 Ignon et al. Jan 2022 B2
11224728 Ignon et al. Jan 2022 B2
11241357 Ignon et al. Feb 2022 B2
11247039 Schwarz Feb 2022 B2
11278101 Jeannin et al. Mar 2022 B2
11291474 Nicolas et al. Apr 2022 B2
11291498 Slatkine et al. Apr 2022 B2
11311721 Ebbers et al. Apr 2022 B2
11337745 Kim May 2022 B2
11337755 Hancock et al. May 2022 B2
11351063 Locke et al. Jun 2022 B2
11419678 Deem et al. Aug 2022 B2
11446477 Ignon Sep 2022 B2
11452852 Quan et al. Sep 2022 B2
11497553 Reinhard et al. Nov 2022 B2
11504148 Friend Nov 2022 B2
11517350 Ignon et al. Dec 2022 B2
11540882 Masotti et al. Jan 2023 B2
11547840 Ignon et al. Jan 2023 B2
11590345 Danitz et al. Feb 2023 B2
11602629 Schwarz et al. Mar 2023 B2
11612726 Ignon et al. Mar 2023 B2
11717326 Ignon et al. Aug 2023 B2
20010023351 Eilers Sep 2001 A1
20010037118 Shadduck Nov 2001 A1
20010049511 Coleman et al. Dec 2001 A1
20020016601 Shadduck Feb 2002 A1
20020040199 Klopotek Apr 2002 A1
20020041891 Cheski Apr 2002 A1
20020058952 Weber et al. May 2002 A1
20020099356 Unger et al. Jul 2002 A1
20020107527 Burres Aug 2002 A1
20020128663 Mercier et al. Sep 2002 A1
20020133110 Citow Sep 2002 A1
20020133176 Parkin et al. Sep 2002 A1
20020151826 Ramey et al. Oct 2002 A1
20020151908 Mallett, Sr. et al. Oct 2002 A1
20020162863 Brincat Nov 2002 A1
20020188261 Hruska Dec 2002 A1
20020198488 Yao Dec 2002 A1
20030012415 Cossel Jan 2003 A1
20030018252 Duchon et al. Jan 2003 A1
20030060834 Muldner Mar 2003 A1
20030093040 Mikszta et al. May 2003 A1
20030093089 Greenberg May 2003 A1
20030097139 Karasiuk May 2003 A1
20030135388 Martucci et al. Jul 2003 A1
20030167032 Ignon Sep 2003 A1
20030187462 Chang Oct 2003 A1
20030208159 Ignon et al. Nov 2003 A1
20030212127 Glassman et al. Nov 2003 A1
20030212415 Karasiuk Nov 2003 A1
20040005349 Neev Jan 2004 A1
20040010222 Nunomura et al. Jan 2004 A1
20040010269 Grimes et al. Jan 2004 A1
20040015139 La Bianco Jan 2004 A1
20040087972 Mulholland et al. May 2004 A1
20040092895 Harmon May 2004 A1
20040092959 Bernaz May 2004 A1
20040097967 Ignon May 2004 A1
20040122447 Harmon et al. Jun 2004 A1
20040127914 Chung Jul 2004 A1
20040138680 Twitchell et al. Jul 2004 A1
20040143274 Shadduck Jul 2004 A1
20040162565 Carson et al. Aug 2004 A1
20040166172 Rosati et al. Aug 2004 A1
20040176823 Island et al. Sep 2004 A1
20040210280 Liedtke Oct 2004 A1
20040219179 McDaniel Nov 2004 A1
20040229295 Marchitto et al. Nov 2004 A1
20040236291 Zelickson et al. Nov 2004 A1
20040236375 Redding, Jr. Nov 2004 A1
20040243149 Lee, Jr. Dec 2004 A1
20040254587 Park Dec 2004 A1
20040267285 Chang Dec 2004 A1
20050015077 Kuklin et al. Jan 2005 A1
20050037034 Rhoades Feb 2005 A1
20050038377 Redding, Jr. Feb 2005 A1
20050038448 Chung Feb 2005 A1
20050059940 Weber et al. Mar 2005 A1
20050065461 Redding, Jr. Mar 2005 A1
20050070977 Molina Mar 2005 A1
20050075599 Redding, Jr. Apr 2005 A1
20050080465 Zelickson et al. Apr 2005 A1
20050084509 Bernstein Apr 2005 A1
20050148958 Rucinski Jul 2005 A1
20050154333 Mulholland et al. Jul 2005 A1
20050203111 David Sep 2005 A1
20050203593 Shanks et al. Sep 2005 A1
20050209611 Greenberg Sep 2005 A1
20050283176 Law Dec 2005 A1
20060002960 Zoeteweij et al. Jan 2006 A1
20060015059 Redding, Jr. Jan 2006 A1
20060058714 Rhoades Mar 2006 A1
20060100567 Marchitto et al. May 2006 A1
20060116674 Goble et al. Jun 2006 A1
20060161178 Lee Jul 2006 A1
20060184071 Klopotek Aug 2006 A1
20060189964 Anderson Aug 2006 A1
20060191562 Numomura Aug 2006 A1
20060200099 La Bianco et al. Sep 2006 A1
20060200172 Shadduck Sep 2006 A1
20060200173 Shadduck Sep 2006 A1
20060200213 McDaniel Sep 2006 A1
20060212025 McDaniel Sep 2006 A1
20060212029 Villacampa et al. Sep 2006 A1
20060222445 Chuang Oct 2006 A1
20060235371 Wakamatsu et al. Oct 2006 A1
20060253078 Wu et al. Nov 2006 A1
20060253079 McDonough et al. Nov 2006 A1
20060253125 Ignon Nov 2006 A1
20060264893 Sage, Jr. et al. Nov 2006 A1
20060264926 Kochamba Nov 2006 A1
20060269580 Cole et al. Nov 2006 A1
20060278661 Cooper et al. Dec 2006 A1
20070005078 Hart et al. Jan 2007 A1
20070020321 Redding et al. Jan 2007 A1
20070043382 Cheney Feb 2007 A1
20070049901 Wu et al. Mar 2007 A1
20070065515 Key Mar 2007 A1
20070073327 Giovannoli Mar 2007 A1
20070078290 Esenaliev Apr 2007 A1
20070088245 Babaev et al. Apr 2007 A1
20070088371 Karasiuk Apr 2007 A1
20070093694 Fassuliotis et al. Apr 2007 A1
20070123808 Rhoades May 2007 A1
20070139630 Kleman et al. Jun 2007 A1
20070149991 Mulholland Jun 2007 A1
20070154502 Hattendorf et al. Jul 2007 A1
20070156124 Ignon et al. Jul 2007 A1
20070178121 First et al. Aug 2007 A1
20070198031 Kellogg Aug 2007 A1
20070208353 Shadduck Sep 2007 A1
20070232987 Diaz et al. Oct 2007 A1
20070239079 Manstein et al. Oct 2007 A1
20070239173 Khalaj Oct 2007 A1
20070255355 Altshuler et al. Nov 2007 A1
20070264625 DeBenedictis et al. Nov 2007 A1
20070270738 Wu et al. Nov 2007 A1
20080009802 Lambino et al. Jan 2008 A1
20080015555 Manstein et al. Jan 2008 A1
20080027328 Klopotek et al. Jan 2008 A1
20080027518 Island et al. Jan 2008 A1
20080091126 Greenburg Apr 2008 A1
20080091179 Durkin et al. Apr 2008 A1
20080103563 Powell May 2008 A1
20080119781 King May 2008 A1
20080132914 Bossard et al. Jun 2008 A1
20080139974 Da Silva Jun 2008 A1
20080146970 Litman et al. Jun 2008 A1
20080154161 Abbott Jun 2008 A1
20080154183 Baker Jun 2008 A1
20080161799 Stangenes et al. Jul 2008 A1
20080188840 Johnson et al. Aug 2008 A1
20080193493 Rhoades Aug 2008 A1
20080200861 Shalev et al. Aug 2008 A1
20080200863 Chomas et al. Aug 2008 A1
20080208146 Brandwein et al. Aug 2008 A1
20080208179 Chan et al. Aug 2008 A1
20080214987 Xu Sep 2008 A1
20080215068 Hart et al. Sep 2008 A1
20080221548 Danenberg et al. Sep 2008 A1
20080234626 Chelak Sep 2008 A1
20080243039 Rhoades Oct 2008 A1
20080287864 Rosenberg Nov 2008 A1
20080300529 Reinstein Dec 2008 A1
20080300552 Cichocki et al. Dec 2008 A1
20090048557 Yeshurun et al. Feb 2009 A1
20090053390 Sakou et al. Feb 2009 A1
20090062815 Karasiuk et al. Mar 2009 A1
20090099091 Hantash Apr 2009 A1
20090099093 Hantash Apr 2009 A1
20090118684 Da Silva et al. May 2009 A1
20090124985 Hasenoehrl et al. May 2009 A1
20090132012 Shanks May 2009 A1
20090138026 Wu May 2009 A1
20090171191 Patrick et al. Jul 2009 A1
20090171194 Patrick et al. Jul 2009 A1
20090177171 Ignon et al. Jul 2009 A1
20090192442 Ignon et al. Jul 2009 A1
20090222023 Boone, III et al. Sep 2009 A1
20090254014 Son Oct 2009 A1
20090299237 Rhoades Dec 2009 A1
20100023003 Mulholland Jan 2010 A1
20100045427 Boone, III et al. Feb 2010 A1
20100048980 De Jong et al. Feb 2010 A1
20100049177 Boone, III et al. Feb 2010 A1
20100049210 Boone, III et al. Feb 2010 A1
20100056847 De Jong et al. Mar 2010 A1
20100063565 Beerwerth et al. Mar 2010 A1
20100217357 Da Silva Aug 2010 A1
20100305495 Anderson et al. Dec 2010 A1
20110054490 Hart Mar 2011 A1
20110060270 Eppstein Mar 2011 A1
20110066162 Cohen Mar 2011 A1
20110082415 Ignon et al. Apr 2011 A1
20110067761 King Jun 2011 A1
20110190726 Hantash et al. Aug 2011 A1
20110251523 Kim Oct 2011 A1
20110264028 Ramdas et al. Oct 2011 A1
20110270137 Goren et al. Nov 2011 A1
20110270364 Kreindel et al. Nov 2011 A1
20110295273 Waldron et al. Dec 2011 A1
20120022435 Ignon et al. Jan 2012 A1
20120041338 Chickering, III et al. Feb 2012 A1
20120041523 Solomon et al. Feb 2012 A1
20120109041 Munz May 2012 A1
20120109043 Zhou et al. May 2012 A1
20120136374 Karasiuk May 2012 A1
20120171636 Groman Jul 2012 A1
20120259252 Thorn-Leeson et al. Oct 2012 A1
20120289885 Cottrell et al. Nov 2012 A1
20120302929 Tkachenko Nov 2012 A1
20130004230 Kirk, III et al. Jan 2013 A1
20130018317 Bobroff et al. Jan 2013 A1
20130066336 Boone, III et al. Mar 2013 A1
20130085421 Gillespie et al. Apr 2013 A1
20130096546 Mirkov et al. Apr 2013 A1
20130096577 Shadduck Apr 2013 A1
20130102978 Ignon et al. Apr 2013 A1
20130144207 Gonon Jun 2013 A1
20130144280 Eckhouse et al. Jun 2013 A1
20130158547 David Jun 2013 A1
20130204238 Lederman et al. Aug 2013 A1
20130226075 Hennings et al. Aug 2013 A1
20130226269 Eckhouse et al. Aug 2013 A1
20130261534 Niezgoda et al. Oct 2013 A1
20130268032 Neev Oct 2013 A1
20130310906 Neev Nov 2013 A1
20130317314 Lampson Nov 2013 A1
20130345616 Chang Dec 2013 A1
20140031801 Giovannoli Jan 2014 A1
20140079686 Barman et al. Mar 2014 A1
20140081251 Giovannoli Mar 2014 A1
20140094718 Feldman Apr 2014 A1
20140114234 Redding, Jr. Apr 2014 A1
20140135798 David May 2014 A1
20140234004 Thorpe et al. Aug 2014 A1
20140243589 Rowan Aug 2014 A1
20140316492 Min et al. Oct 2014 A1
20140343481 Ignon Nov 2014 A1
20140343574 Ignon et al. Nov 2014 A1
20140378887 Chang et al. Dec 2014 A1
20150032047 Ignon et al. Jan 2015 A1
20150039060 Paulussen et al. Feb 2015 A1
20150141877 Feldman May 2015 A1
20150157496 Horton et al. Jun 2015 A1
20150202007 Mainstein et al. Jul 2015 A1
20150230824 Shadduck Aug 2015 A1
20150230825 Shadduck Aug 2015 A1
20150231379 Ignon et al. Aug 2015 A1
20150265822 Ignon et al. Sep 2015 A1
20150272632 Seelig Oct 2015 A1
20150290442 Ignon et al. Oct 2015 A1
20150313993 Bock Nov 2015 A1
20150351868 Groman Dec 2015 A1
20160015962 Maragheh et al. Jan 2016 A1
20160018100 Batt et al. Jan 2016 A1
20160038183 Ignon et al. Feb 2016 A1
20160175609 Dye et al. Jun 2016 A1
20160220849 Knowlton Aug 2016 A1
20160235257 Daffer Aug 2016 A1
20160250415 Yagi et al. Sep 2016 A1
20160270850 Manstein et al. Sep 2016 A1
20160270851 Moench et al. Sep 2016 A1
20160287333 Morrison Oct 2016 A1
20160324578 Manstein et al. Nov 2016 A1
20170036002 Ignon et al. Feb 2017 A1
20170043150 Kim Feb 2017 A1
20170065801 Ignon et al. Mar 2017 A1
20170065829 Ku Mar 2017 A1
20170106206 Seckel Apr 2017 A1
20170128319 Decaux et al. May 2017 A1
20170157419 Jeong Jun 2017 A1
20170196759 Palomaki et al. Jul 2017 A1
20170209894 Sporrer Jul 2017 A1
20170252105 Deem et al. Sep 2017 A1
20170291007 Dubey et al. Oct 2017 A1
20170340356 Presser et al. Nov 2017 A1
20170343308 Wojciechowski, III et al. Nov 2017 A1
20180008500 Anderson et al. Jan 2018 A1
20180140329 Beijens et al. May 2018 A1
20180185675 Kern et al. Jul 2018 A1
20180310979 Peled et al. Nov 2018 A1
20180318568 Ignon et al. Nov 2018 A1
20180326191 Bansal et al. Nov 2018 A1
20190009110 Gross et al. Jan 2019 A1
20190009111 Myhr et al. Jan 2019 A1
20190070069 Gertner et al. Mar 2019 A1
20190076193 Clementi et al. Mar 2019 A1
20190083161 Harle et al. Mar 2019 A1
20190133642 Ignon et al. May 2019 A1
20190143089 Ignon et al. May 2019 A1
20190151637 Groop et al. May 2019 A1
20190168016 Anderson et al. Jun 2019 A1
20190183562 Widgerow Jun 2019 A1
20190209859 Quisenberry et al. Jul 2019 A1
20190223914 Ignon et al. Jul 2019 A1
20190224501 Burdette Jul 2019 A1
20190239939 Boll et al. Aug 2019 A1
20190240110 Sedic Aug 2019 A1
20190240502 Anderson et al. Aug 2019 A1
20190257320 Petit et al. Aug 2019 A1
20190274759 Royon et al. Sep 2019 A1
20190275320 Kim et al. Sep 2019 A1
20190336740 Ignon et al. Nov 2019 A1
20190366067 Ginggen et al. Dec 2019 A1
20200009007 Shadduck Jan 2020 A1
20200016342 Ignon Jan 2020 A1
20200030627 Eltorai et al. Jan 2020 A1
20200101312 Pai et al. Apr 2020 A1
20200114116 Dubey et al. Apr 2020 A1
20200121354 Ginggen et al. Apr 2020 A1
20200171289 Ignon et al. Jun 2020 A1
20200179220 Jablow Jun 2020 A1
20200206072 Capelli et al. Jul 2020 A1
20200254273 Jafari et al. Aug 2020 A1
20200275945 Knowlton Sep 2020 A1
20200288843 Verheem Sep 2020 A1
20200289161 Scooros Sep 2020 A1
20200306555 Ebbesson Oct 2020 A1
20200316270 Dijkstra et al. Oct 2020 A1
20200330754 Kim et al. Oct 2020 A1
20200338586 Park Oct 2020 A1
20200367961 Podmore et al. Nov 2020 A1
20200390468 Alexander Dec 2020 A1
20210001148 Verheem Jan 2021 A1
20210052292 Karni Feb 2021 A1
20210085367 Shadduck et al. Mar 2021 A1
20210128416 Danto May 2021 A1
20210145479 Ignon et al. May 2021 A1
20210145480 Ignon et al. May 2021 A1
20210145481 Ignon et al. May 2021 A1
20210154093 Boone, III et al. May 2021 A1
20210154453 Ignon et al. May 2021 A1
20210154454 Ignon et al. May 2021 A1
20210154455 Ignon et al. May 2021 A1
20210177463 Ignon et al. Jun 2021 A1
20210220631 Ok et al. Jul 2021 A1
20210236342 Long et al. Aug 2021 A1
20210236347 Carver Aug 2021 A1
20210236836 Schwarz et al. Aug 2021 A1
20210242657 Yi et al. Aug 2021 A1
20210259914 Holbert Aug 2021 A1
20210267625 Carver Sep 2021 A1
20210268304 Lee Sep 2021 A1
20210275406 Danto Sep 2021 A1
20210282855 Boinagrov et al. Sep 2021 A1
20210283421 Kang et al. Sep 2021 A1
20210290430 Kim Sep 2021 A1
20210330356 Del Rosario et al. Oct 2021 A1
20210353922 Ignon et al. Nov 2021 A1
20210361525 Park et al. Nov 2021 A1
20210370049 Moss et al. Dec 2021 A1
20210370089 Anash Dec 2021 A1
20210393478 Bhatti Dec 2021 A1
20210393974 Kim et al. Dec 2021 A1
20210393975 Eltorai et al. Dec 2021 A1
20210395071 Zubrum et al. Dec 2021 A1
20210402208 Edgar Dec 2021 A1
20220001198 Lee Jan 2022 A1
20220001199 Beerwerth et al. Jan 2022 A1
20220008122 Johnston et al. Jan 2022 A1
20220032082 Shenfarber et al. Feb 2022 A1
20220054189 Wootten Feb 2022 A1
20220071491 Bae et al. Mar 2022 A1
20220072332 Park et al. Mar 2022 A1
20220087891 Goodman et al. Mar 2022 A1
20220111198 Jung Apr 2022 A1
20220117632 Walker et al. Apr 2022 A1
20220125706 Horinek et al. Apr 2022 A1
20220126014 Cederna et al. Apr 2022 A1
20220133407 Anderson et al. May 2022 A1
20220175443 Slatkine et al. Jun 2022 A1
20220176092 Quan et al. Jun 2022 A1
20220203112 Iger et al. Jun 2022 A1
20220211424 Wootten et al. Jul 2022 A1
20220211988 Ignon et al. Jul 2022 A1
20220218562 Capelli et al. Jul 2022 A1
20220226668 Lee et al. Jul 2022 A1
20220233400 Oh et al. Jul 2022 A1
20220241107 Kim et al. Aug 2022 A1
20220241146 Jeong Aug 2022 A1
20220268536 Stephenson et al. Aug 2022 A1
20220287910 Boone, III et al. Sep 2022 A9
20220312940 Hong et al. Oct 2022 A1
20220362529 Castro Nov 2022 A1
20220401714 Quan et al. Dec 2022 A1
20220409276 Choi Dec 2022 A1
20230012684 Ignon et al. Jan 2023 A1
20230014299 Lee, Jr. et al. Jan 2023 A1
20230018295 Ignon et al. Jan 2023 A1
20230019979 Deem et al. Jan 2023 A1
20230033217 Ignon et al. Feb 2023 A1
20230033761 Ignon et al. Feb 2023 A1
20230042047 Kim et al. Feb 2023 A1
20230062185 Nazarian et al. Mar 2023 A1
20230104221 Aharon Apr 2023 A1
20230123145 Ko Apr 2023 A1
20230158282 Ignon et al. May 2023 A1
Foreign Referenced Citations (108)
Number Date Country
400 305 Dec 1995 AT
1 014 299 May 1999 AU
2 340 154 Sep 2002 CA
2784209 Aug 2011 CA
1708261 Dec 2005 CN
107920948 Apr 2018 CN
306995346 Dec 2021 CN
59 95 21 Jul 1934 DE
24 15 633 Oct 1975 DE
33 38 057 Aug 1984 DE
34 21 390 Dec 1985 DE
234 608 Apr 1986 DE
35 03 343 Aug 1986 DE
83 30 191 Jun 1987 DE
37 40 902 Dec 1988 DE
42 37 940 May 1993 DE
298 08 395 Aug 1998 DE
10 2004 015815 Nov 2005 DE
DES. 8794184-0001 Dec 2021 EM
DES. 8880371-0001 May 2022 EM
0 258 901 Sep 1987 EP
0479121 Apr 1992 EP
0 564 392 Mar 1993 EP
0 784 997 Jul 1997 EP
1238643 Apr 2000 EP
1 453 558 Sep 2004 EP
2206483 Jul 2010 EP
2544563 Sep 2015 EP
2 106 780 Mar 2016 EP
3 217 899 May 2016 EP
2865867 May 2016 EP
2240099 Feb 2018 EP
3 302 319 Apr 2018 EP
2967633 Apr 2018 EP
3319573 May 2018 EP
3 340 908 Jul 2018 EP
2451367 Jan 2020 EP
3388006 Mar 2020 EP
2618797 Apr 2020 EP
3237055 Aug 2020 EP
3795204 Mar 2021 EP
3437575 Apr 2021 EP
1 037 776 Apr 1998 ES
2 712 172 May 1995 FR
2 773 461 Jul 1999 FR
1 372 609 Oct 1974 GB
2306351 May 1997 GB
2585500 Jan 2021 GB
553 076 Dec 1956 IT
118 49 22 Mar 1985 IT
S55-034863 Aug 1963 JP
H05-042060 Feb 1993 JP
1993-088552 Dec 1993 JP
1997-294747 Nov 1997 JP
2003-534881 Nov 2003 JP
2003-339713 Dec 2003 JP
2004-275721 Oct 2004 JP
2006-503627 Feb 2006 JP
2006-204767 Oct 2006 JP
2010042243 Feb 2010 JP
2012527967 Nov 2012 JP
2013-215621 Oct 2013 JP
5508285 Mar 2014 JP
D1581877 Jul 2017 JP
D1609357 Jun 2018 JP
2018-527052 Sep 2018 JP
20-0280320 Jul 2002 KR
10-20070070173 Jul 2007 KR
10-2018-0030607 Mar 2018 KR
10-1836310 Mar 2018 KR
D214226 Sep 2021 TW
WO 1994024980 Nov 1994 WO
WO 1997000707 Jan 1997 WO
WO 1997011650 Mar 1997 WO
WO 2000015300 Mar 2000 WO
WO 0079540 Dec 2000 WO
WO 200193931 Dec 2001 WO
WO 2004108091 Dec 2001 WO
WO 2003073917 Sep 2003 WO
WO 2004037098 May 2004 WO
WO 2004037287 May 2004 WO
WO 2005061042 Jul 2005 WO
WO 2005070313 Aug 2005 WO
WO 2006018731 Feb 2006 WO
WO 2006031413 Mar 2006 WO
WO 2007114904 Oct 2007 WO
WO 2008012324 Jan 2008 WO
WO 2009086182 Jul 2009 WO
WO 2009088884 Jul 2009 WO
WO 2009097451 Aug 2009 WO
WO 2010022396 Feb 2010 WO
WO 2010068960 Jun 2010 WO
WO 2010151704 Dec 2010 WO
WO 2011006009 Jan 2011 WO
WO 2011110840 Sep 2011 WO
WO 2012145667 Oct 2012 WO
WO 2013030117 Mar 2013 WO
WO 2014091035 Jun 2014 WO
WO 2014151104 Sep 2014 WO
WO 2016052818 Apr 2016 WO
WO 2016106396 Jun 2016 WO
WO 2017007939 Jan 2017 WO
WO 2017111481 Jun 2017 WO
WO 2021018765 Feb 2021 WO
WO 2021113343 Jun 2021 WO
WO 2022099318 May 2022 WO
WO 2023039524 Mar 2023 WO
WO 2023064718 Apr 2023 WO
Non-Patent Literature Citations (94)
Entry
U.S. Appl. No. 13/620,164, filed Sep. 14, 2012, Instruments and Techniques for Controlled Removal of Epidermal Layers.
U.S. Appl. No. 15/953,337, filed Apr. 13, 2018, Instruments and Techniques for Controlled Removal of Epidermal Layers.
U.S. Appl. No. 16/517,268, filed Jul. 19, 2019, Devices and Methods for Treating Skin.
U.S. Appl. No. 29/679,299, filed Feb. 4, 2019, Skin Treatment System.
U.S. Appl. No. 29/679,306, filed Feb. 4, 2019, Handpiece Assembly Tip.
U.S. Appl. No. 29/679,302, filed Feb. 4, 2019, Handpiece Assembly Tip.
U.S. Appl. No. 17/163,237, filed Jan. 29, 2021, Devices, Systems and Methods for Treating the Skin.
U.S. Appl. No. 17/163,240, filed Jan. 29, 2021, Devices, Systems and Methods for Treating the Skin.
U.S. Appl. No. 16/246,306, filed Jan. 11, 2019, Devices and Methods for Treating the Skin Using a Porous Member.
U.S. Appl. No. 15/204,939, filed Jul. 7, 2016, Devices, Systems and Methods for Promoting Hair Growth.
File History of Reexamination U.S. Appl. No. 90/013,284, filed Jul. 2, 2014 (Reexamination of U.S. Pat. No. 6,241,739, issued Jun. 5, 2001).
Cox III et al., Decreased Splatter in Dermabrasion, Arch Facial Plastic Surgery, Jan.-Mar. 2000, vol. 2, pp. 23-26.
Ditre et al., Effect of α-hydroxy acids on photoaged skin: A pilot clinical, histologic, and ultrastructural study, Journal of American Academy of Dermatology, Feb. 1996, vol. 34, No. 2, Part 1, pp. 187-195.
Harris et al., Combining Manual Dermasanding with Low Strength Trichloroacetic Acid to Improve Antinically Injured Skin, The Journal of Dermatologic Surgery and Oncology, Jul. 1994, vol. 20, No. 7, pp. 436-442.
Hydrafacial® Tower—User guide. Edge Systems. Revised Jun. 23, 2016. p. 16.
Microdermabrader Pepita Instruction Manual, Mattioli Engineering S.R.L., PEP_USA2.doc Rev 1.1, Sep. 29, 1997.
International Search Report and Written Opinion for related PCT appl. PCT/US2008/088576 dated Feb. 19, 2009.
U.S. Appl. No. 17/165,820, filed Feb. 2, 2021, Devices and Methods for Treating Skin.
U.S. Appl. No. 17/165,807, filed Feb. 2, 2021, Devices and Methods for Treating Skin.
U.S. Appl. No. 17/163,199, filed Jan. 29, 2021, Devices, Systems and Methods for Treating the Skin.
U.S. Appl. No. 29/826,153, filed Feb. 9, 2022, Dual Treatment Device for Treating Acne or Wrinkles.
U.S. Appl. No. 09/648,025 (U.S. Pat. No. 6,641,591), filed Aug. 25, 2000, Instruments and Techniques for Controlled Removal of Epidermal Layers.
U.S. Appl. No. 10/699,747 (U.S. Pat. No. 7,789,886), filed Nov. 3, 2003, Instruments and Techniques for Controlled Removal of Epidermal Layers.
U.S. Appl. No. 11/739,615 (U.S. Pat. No. 8,337,513), filed Apr. 24, 2007, Instruments and Techniques for Controlled Removal of Epidermal Layers.
U.S. Appl. No. 11/417,709 (U.S. Pat. No. 8,066,716), filed May 3, 2006, Instruments and Techniques for Controlled Removal of Epidermal Layers.
U.S. Appl. No. 11/417,396 (U.S. Pat. No. 7,678,120), filed May 3, 2006, Instruments and Techniques for Controlled Removal of Epidermal Layers.
U.S. Appl. No. 14/702,509 (U.S. Pat. No. 9,775,646), filed May 1, 2015, Devices and Systems for Treating the Skin Using Vacuum.
U.S. Appl. No. 14/702,486 (U.S. Pat. No. 9,468,464), filed May 1, 2015, Methods for Treating the Skin Using Vacuum.
U.S. Appl. No. 11/392,348 (U.S. Pat. No. 8,048,089), filed Mar. 29, 2006, Apparatus and Methods for Treating the Skin.
U.S. Appl. No. 13/267,554 (U.S. Pat. No. 9,474,886), filed Oct. 6, 2011, Removable Tips for Skin Treatment Systems.
U.S. Appl. No. 14/698,673 (U.S. Pat No. 9,550,052), filed Apr. 28, 2015, Console System for the Treatment of Skin.
U.S. Appl. No. 14/698,713 (U.S. Pat. No. 9,662,482), filed Apr. 28, 2015, Methods and Systems for Extraction of Materials From Skin.
U.S. Appl. No. 14/700,789 (U.S. Pat. No. 9,814,868), filed Apr. 30, 2015, Tip With Embedded Materials for Skin Treatment.
U.S. Appl. No. 15/660,750 (U.S. Pat. No. 10/357,641), filed Jul. 26, 2017, Tips for Skin Treatment Device.
U.S. Appl. No. 15/660,777 (U.S. Pat. No. 10/357,642), filed Jul. 26, 2017, Removable Tips for Use With Skin Treatment Systems.
U.S. Appl. No. 16/517,268 (U.S. Pat. No. 11,446,477), filed Jul. 19, 2019, Devices and Methods for Treating Skin.
U.S. Appl. No. 17/165,820 (U.S. Pat. No. 11,547,840), filed Feb. 2, 2021, Devices and Methods for Treating Skin.
U.S. Appl. No. 17/165, 807 (U.S. Pat. No. 11,612,726), filed Feb. 2, 2021, Devices and Methods for Treating Skin.
U.S. Appl. No. 18/094,884, filed Jan. 9, 2023, Devices and Methods for Treating Skin.
U.S. Appl. No. 09/294,254 (U.S. Pat. No. 6,162,232), filed Apr. 19, 1999, Instruments and Techniques for High-Velocity Fluid Abrasion of Epidermal Layers With Skin Cooling.
U.S. Appl. No. 09/475,480 (U.S. Pat. No. 6,299,620), filed Dec. 30, 1999, Instruments and Techniques for Inducing Neocollagenesis in Skin Treatments.
U.S. Appl. No. 09/475,479 (U.S. Pat. No. 6,387,103), filed Dec. 30, 1999, Instruments and Techniques for Inducing Neocollagenesis in Skin Treatments.
U.S. Appl. No. 11/370,200, filed Mar. 7, 2006, Microdermabrasion Method And Apparatus.
U.S. Appl. No. 12/362,353 (U.S. Pat. No. 9,056,193), filed Jan. 29, 2009, Apparatus and Method for Treating the Skin.
U.S. Appl. No. 14/734,995 (U.S. Pat. No. 11,020,577), filed Jun. 9, 2015, Devices and Systems for Treating Skin Surfaces.
U.S. Appl. No. 17/332,897, filed May 27, 2021, Devices, Systems, and Methods for Treating the Skin.
U.S. Appl. No. 17/952,569, filed Sep. 26, 2022, Devices, Systems, and Methods for Treating the Skin.
U.S. Appl. No. 17/952,665, filed Sep. 26, 2022, Devices, Systems, and Methods for Treating the Skin.
U.S. Appl. No. 12/832,663 (U.S. Pat. No. 8,814,836), filed Jul. 8, 2010, Devices, Systems and Methods for Treating the Skin Using Time-Release Substances.
U.S. Appl. No. 14/455,762 (U.S. Pat. No. 9,642,997), filed Aug. 8, 2014, Devices for Treating Skin Using Treatment Materials Located Along a Tip.
U.S. Appl. No. 15/588,102 (U.S. Pat. No. 10,556,097), filed May 5, 2017, Devices for Treating Skin Using Treatment Materials Located Along a Tip.
U.S. Appl. No. 16/784,850, filed Feb. 7, 2020, Devices and Methods for Treating Skin.
U.S. Appl. No. 12/346,582 (U.S. Pat. No. 8,343,116), filed Dec. 30, 2008, Apparatus and Method for Treating the Skin.
U.S. Appl. No. 13/620,376 (U.S. Pat. No. 9,486,615), filed Sep. 14, 2012, Microdermabrasion Apparatus and Method.
U.S. Appl. No. 15/344,357 (U.S. Pat. No. 10,556,096), filed Nov. 4, 2016, Devices and Methods for Skin Treatment.
U.S. Appl. No. 09/540,945 (U.S. Pat. No. 6,592,595), filed Mar. 31, 2000, Microdermabrasion and Suction Massage Apparatus and Method.
U.S. Appl. No. 09/698,409 (U.S. Pat. No. 6,527,783), filed Oct. 27, 2000, Microdermabrasion and Suction Massage Apparatus and Method.
U.S. Appl. No. 10/177,173 (U.S. Pat. No. 6,673,082), filed Jun. 20, 2002, Microdermabrasion Handpiece With Supply and Return Lumens.
U.S. Appl. No. 10/315,478 (U.S. Pat. No. 6,942,649), filed Dec. 10, 2002, Microdermabrasion Fluid Application System and Method.
U.S. Appl. No. 09/699,220 (U.S. Pat. No. 6,629,983), filed Oct. 27, 2000, Apparatus and Method for Skin/Surface Abrasion.
U.S. Appl. No. 14/211,089 (U.S. Pat. No. 10,238,812), filed Mar. 14, 2014, Skin Treatment Systems and Methods Using Needles.
U.S. Appl. No. 16/363,310, filed Mar. 25, 2019, Skin Treatment Systems and Methods Using Needles.
U.S. Appl. No. 14/211,290 (U.S. Pat. No. 9,566,088), filed Mar. 14, 2014, Devices, Systems and Methods for Treating the Skin.
U.S. Appl. No. 15/430,209 (U.S. Pat. No. 10,251,675), filed Feb. 10, 2017, Devices, Systems and Methods for Treating the Skin.
U.S. Appl. No. 16/376,956, filed Apr. 5, 2019, Devices, Systems and Methods for Treating the Skin.
U.S. Appl. No. 17/952,721, Sep. 26, 2022, Devices, Systems, and Methods for Treating the Skin.
U.S. Appl. No. 17/952,676, filed Sep. 26, 2022, Devices, Systems, and Methods for Treating the Skin.
U.S. Appl. No. 14/774,641 (U.S. Pat. No. 10,172,644), filed Sep. 10, 2015, Devices, Systems and Methods for Treating the Skin.
U.S. Appl. No. 16/241,572 (U.S. Pat. No. 10,993,743), filed Jan. 7, 2019, Devices, Systems and Methods for Treating the Skin.
U.S. Appl. No. 17/163,128, filed Jan. 29, 2021, Devices, Systems and Methods for Treating the Skin.
U.S. Appl. No. 17/163,199 (U.S. Pat. No. 11,517,350), filed Jan. 29, 2021, Devices, Systems and Methods for Treating the Skin.
U.S. Appl. No. 17/163,237 (U.S. Pat. No. 11,202,657), filed Jan. 29, 2021, Devices, Systems and Methods for Treating the Skin.
U.S. Appl. No. 17/163,240 (U.S. Pat. No. 11,213,321), filed Jan. 29, 2021, Devices, Systems and Methods for Treating the Skin.
U.S. Appl. No. 14/998,375 (U.S. Pat. No. 9,498,610), filed Dec. 23, 2015, Devices and Methods for Treating the Skin Using a Rollerball or a Wicking Member.
U.S. Appl. No. 15/354,754 (U.S. Pat. No. 10,035,007), filed Nov. 17, 2016, Devices and Methods for Treating the Skin.
U.S. Appl. No. 16/040,397, filed Jul. 19, 2018, Devices and Methods for Treating the Skin.
U.S. Appl. No. 17/164,580, filed Feb. 1, 2021, Devices and Methods for Treating the Skin.
U.S. Appl. No. 15/498,416 (U.S. Pat. No. 10,179,229), filed Apr. 26, 2017, Devices and Methods for Treating the Skin Using a Porous Member.
U.S. Appl. No. 16/246,306 (U.S. Pat. No. 11,224,728), filed Jan. 11, 2019, Devices and Methods for Treating the Skin Using a Porous Member.
U.S. Appl. No. 17/576,888, filed Jan. 14, 2022, Devices and Methods for Treating the Skin.
U.S. Appl. No. 15/204,939 (U.S. Pat. No. 11,241,357), filed Jul. 7, 2016, Devices, Systems and Methods for Promoting Hair Growth.
U.S. Appl. No. 17/592,432, filed Feb. 3, 2022, Devices, Systems and Methods for Improving Scalp Health.
U.S. Appl. No. 18/035,723, filed May 5, 2023, Devices, Systems and Methods for Treating the Skin.
U.S. Appl. No. 29/811,066, filed Oct. 11, 2021, Skin Treatment System.
U.S. Appl. No. 29/807,430, filed Sep. 10, 2021, Skin Treatment Device.
U.S. Appl. No. 29/807,428, filed Sep. 10, 2021, Container for a Skin Treatment Device.
U.S. Appl. No. 29/829,476, filed Mar. 4, 2022, Light Therapy Device for Skin Care.
U.S. Appl. No. 29/811,070, filed Oct. 11, 2021, Skin Treatment Tip.
U.S. Appl. No. 29/826,153, filed Feb. 9, 2022, Dual Treating Device for Treating Acne or Wrinkles.
U.S. Appl. No. 29/854,067, filed Sep. 21, 2022, Treatment Device for Skin.
U.S. Appl. No. 29/884,441, filed Feb. 10, 2023, Skin Treatment Tip.
Amazon, Fazjeune 7 Color LED Light, LED Face Mask Skin Rejevenation PDT Photon Facial Skin Care Mask Skin Tightening Lamp SPA Face Device Beauty Salon Equipment Anti-aging Remove Wrinkle, Customer reviewed on Sep. 2020, retrieved from internet at https://www.amazon.com/FAZJEUNE-Rejuvenation-Tightening-Equipment-Anti-aging/dp/B08B4M8RQQ/ref=psdc_11061121_t3_B08ZSPZSF4.
Beautimate adjustable Hydra Needle Microneedling Serium Applicator, https://www.beautimate.com/products/adjustable-hydra-needle, first accessed Aug. 12, 2023.
Hydrafacial Hydropeel Vortex Fusion Tips, https://mergesouq.com/products/hydrafacial-hydropeel-vortex-fusion-tips, first accessed Aug. 12, 2023.
Related Publications (1)
Number Date Country
20200171288 A1 Jun 2020 US
Provisional Applications (2)
Number Date Country
61022201 Jan 2008 US
61019196 Jan 2008 US
Continuations (3)
Number Date Country
Parent 15344357 Nov 2016 US
Child 16784044 US
Parent 13620376 Sep 2012 US
Child 15344357 US
Parent 12346582 Dec 2008 US
Child 13620376 US